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Background/Aims: The incidence of oesophageal cancer (OC) is a worldwide problem and is 
incremental among black South African males. The high prevalence of OC may be due to the 
consumption of maize as a staple, often contaminated with mycotoxins. Fusaric acid (FA), a 
neglected mycotoxin, was first isolated from Fusarium heterosporum and a major contaminant 
of maize. FA is known to disrupt mitochondrial energy metabolism, chelate divalent metal 
cations, induce cell death in plants, and has been suggested as an aetiological agent of OC. 
However, the mechanism by which FA causes cytotoxicity in oesophageal cells has not been 
conclusively elucidated. This study investigated FA-induced cytotoxicity and apoptotic 
induction in the SNO OC cell line. 
Methods: SNO cells were treated with a range of FA concentrations (0-500 µg/ml) over 24 h 
and an IC50 was obtained using the MTT assay. The cells were assayed for oxidative stress and 
membrane damage (TBARS, LDH cytotoxicity and glutathione), apoptotic induction (ATP 
levels, caspase-8, -9, -3/7 activities) (Luminometry), single strand DNA and nuclear 
fragmentation (Comet and Hoechst assay). Additionally, relative expression of pro- and anti-
apoptotic proteins were determined using Western Blotting. 
Results: An IC50 of 78.81 µg/ml FA was obtained. Significant antioxidant (glutathione) 
depletion (1.62-fold, p < 0.0001) was consistent with a concomitant increase in reactive oxygen 
species (ROS)-induced lipid peroxidation (1.23-fold, p < 0.05) and extracellular LDH levels 
(1.15-fold, p < 0.005). FA induced apoptosis by significantly increasing Bax expression (1.08-
fold, p < 0.05) and caspase-8, -9 and -3/7 activities (p < 0.05) whilst decreasing ATP levels 
(1.16-fold, p < 0.05) and Bcl-2 expression (1.24-fold, p < 0.05). Further, FA significantly 
increased comet tail lengths (p < 0.0001), PARP-1 cleavage (1.53-fold, p < 0.05) and late stage 
apoptotic body formation in SNO cells. 
Conclusion: FA induced oxidative stress by increasing the level of ROS-induced lipid 
peroxidation resulting in membrane damage and concomitantly reducing antioxidant response, 
Disruption of mitochondrial activity was associated with low ATP levels. Collectively, these 
events triggered the caspase-cascade which compromised DNA integrity and averted its repair, 
leading to cell death via intrinsic and extrinsic apoptosis. Taken together, FA is a cytotoxic 








Oesophageal cancer (OC) is a globally prominent disease and ranks as the sixth most common 
cause of cancer-related deaths worldwide and the second most prevalent cancer among black 
South African men (Siegel et al., 2016). The increasing incidence of OC may be attributed to a 
number of aetiological factors including dietary deficiencies (low consumption of fruits and 
vegetables), drinking very hot liquids, family history, age, achalasia, poor oral hygiene, having 
gastroesophageal reflux disease (GERD) and tylosis (Bravi et al., 2012, Dar et al., 2013, Ballo 
and Millikan, 2015). These factors also include an increase in cancer-causing behaviours, 
particularly excessive smoking, alcohol consumption and consumption of foods contaminated 
with fungi (Nedělník, 2002, Ballo and Millikan, 2015).  
Since the oesophagus is the second organ in the digestive tract, the oesophagus becomes highly 
susceptible to exposure to contaminated food which may be carcinogenic. Maize, the staple 
food of many developing countries, including South Africa, is susceptible to fungal 
contamination, that produce carcinogenic mycotoxins such as fumonisin B1 (Mqoco and Marais, 
2010). In South Africa, rural populations rely on subsistence farming. The harvested crops are 
poorly stored and are susceptible to fungal contamination and proliferation. Contaminated 
maize is normally ground into flour and used as a staple. However, heavily contaminated maize 
is used to prepare traditional home made beer. This beer is consumed mainly by South African 
black men, further exposing them to a potent mycotoxin cocktail that contains alcohol. It has 
been shown that home brewed beers contain many carcinogens (Cousin et al., 2005) and this 
may explain the high incidence of OC in black South African men residing in rural areas. 
Mycotoxin contamination of maize is a global problem (Surai et al., 2008). Over the past 
decade, mycotoxins have been implicated as cytotoxic agents in certain types of cancers (Wang 
et al., 2007, Oda et al., 2010). Mycotoxins are fungal metabolites known to elicit various effects 
in humans. Fusaric acid (FA, 5-butylpicolinic acid), isolated from the fungus Fusarium 
heterosporum, is referred to as a ‘neglected’ mycotoxin since there is limited literature 
regarding the effects of FA on animals and humans (Nedělník, 2002).  
Fusaric acid contains a butyl aliphatic side chain which accentuates its lipophilic properties to 
freely penetrate cell membranes and cause membrane damage (Fernández-Pol, 1998). Since FA 
is a metabolite of picolinic acid and tryptophan, FA contains a pyridine ring which allows 
chelation of divalent metal cations. Chelation would disrupt cellular processes which require 
those cations (Gäumann, 1958). Being a weak acid, FA is able to carry protons across the inner 
mitochondrial (mt) membrane thus destroying the proton gradient across the membrane. This 
process is termed “uncoupling” and hence FA is known as an oxidative phosphorylation 
uncoupler (Bachmann, 1956). 
Membrane disruption and the inhibition of oxidative phosphorylation by FA (Telles-Pupulin et 
al., 1998) will contribute to a highly oxidative environment (Sies, 1985, Sies, 2015), which if 
sustained results in cell death (Circu and Aw, 2010). Prior studies have demonstrated 
suppressive effects of FA on cell survival rates, and DNA damage promoting effects in 
laryngeal cancer (Hep2) and squamous epithelial cells (Ye et al., 2013, Stack et al., 2014), 
however cytotoxicity and cell death were observed in hepatocellular carcinoma (HepG2) cells 





stress in plants (Jiao et al., 2014, Singh and Upadhyay, 2014). In this study, we investigated the 





1.2 Aim & Objectives 
The null hypothesis of this study states that FA has no effect on SNO cells subsequent to acute 
exposure (24 h). 
The aim of this study was: 
To determine the cytotoxic effects of FA on the SNO cell line by measuring expression 
and activities of various cellular molecules following an acute exposure period (24 h).  
The objectives of this study were to investigate the effects of FA after 24 h in SNO cells on: 
• Cellular viability and metabolic activity using the MTT assay. 
• Oxidative capacity of the cell using the TBARS assay to determine the extent of 
reactive oxygen species (ROS)-induced lipid peroxidation [malondialdehyde (MDA) 
generation] and GSH assay to determine the antioxidant response. 
• Cell and mt membrane integrity using the lactate dehydrogenase (LDH) cytotoxicity 
detection assay and quantification of intracellular ATP levels (determine the activity 
of the ATPase complex). 
• The induction/inhibition of the apoptotic pathway using western blotting to determine 
expression of pro- and anti-apoptotic proteins (Bax, Smac/DIABLO, Bcl-2) and 
measuring caspase-3/7, -8 and -9 activities. 
• DNA integrity and cellular and nuclear morphology using the Hoechst staining assay, 
the comet assay, and western blotting to measure the expression of the activated 
fragment of the DNA repair enzyme, Poly (ADP-ribose) polymerase-1 (PARP-1). 
Experimental approach: 
The human oesophageal cancer SNO cell line was utilised as a toxicity model to 
investigate the effects of FA. Cells were exposed to various concentrations of FA over a 
24 h period to determine metabolic output and cell viability. This yielded a 
concentration of FA that produced half the maximum inhibition (IC50). This 







1.3 Literature Review 
1.3.1 Cancer 
Carcinogens cause normal cells to mutate, leading to uncontrollable proliferation of these 
abnormal cells which evade programmed cell death i.e. apoptosis. This uncontrolled cell growth 
is known as cancer. Cancer cells may be benign (inactive) or malignant (active) (Evan and 
Vousden, 2001). Cancer causing agents are represented in Figure 1.1.  
 
Figure 1.1: Cancer causing agents. Cancer can evolve due to various factors, which include 
abnormalities in gene material, carcinogen exposure, dietary exposure to toxins including 
mycotoxins, and infections due to viruses, bacteria and parasites (Prepared by Author). 
	  
Carcinogenesis is the process which a normal cell undergoes to ultimately become a cancer cell. 
There are three stages associated with carcinogenesis: initiation, promotion and progression 
(Pitot, 1993). Initiation occurs due to irreversible gene mutation: transition, deletion or 
transversion. Promotion involves reversible alterations in gene expression. This stage does not 
involve structural alterations of DNA, but rather promoter-receptor interactions which modify 
downstream gene expression. Progression involves malignant cell proliferation and irreversible 
chromosomal instability. This stage is characterised by an ongoing development of 
chromosomal abnormalities leading to independent characteristics, such as metastatic growth, 
invasion and anaplasia (loss of cellular orientation and differentiation) (Pitot, 1993). 
The main types of genes affected by variations induced by carcinogenesis are tumour suppressor 
genes, cellular oncogenes and proto-oncogenes. Mutation of tumour suppressor genes, such as 
DNA repair gene p53, results in change in or loss of function so that its tumour supressing 
activity is altered. Cellular oncogenes are mutated or overexpressed genes in cancer cells. Proto-
oncogenes are the normal genes as compared to oncogenes which stimulate cell cycle and 
regulate proliferation (Oliveira et al., 2007). 
The distinguishing characteristics of cancer include: evasion of immune destruction and 
suppressors of tumours; stimulation of metastasis, angiogenesis, invasion and infinite ability to 
replicate; sustained signals for division; apoptotic resistance and enhanced energy production. 
Inflammation aggravates these hallmarks, eventually compromising genome stability and 
encouraging genetic variation. These hallmarks promote cancer cell survival, among other 
factors, which include decreased cell adhesion and thereby decreased communication between 






Treatments for cancer include radiation and chemotherapy, as well as surgical removal of 
tumours. Chemotherapy involves introducing chemicals to the bloodstream to target tumours 
that have metastasised (migration of cancer cells to new sites in the body). Radiation therapy 
involves using laser beams to target tumours. These treatments are harsh and have serious side 
effects which include destruction of normal cells, suppression of the immune system, nausea, 
fatigue, loss of hair, damage to skin and drug resistance (Gerber, 2008). 
 
1.3.1.1 Oesophageal cancer 
Oesophageal cancer remains one of the most deadly cancers worldwide. It is the 8th most 
common cancer throughout the world, and the 6th most prevalent cause of cancer-related deaths 
worldwide. Oesophageal cancer is also the 2nd most frequent cancer among South African men, 
being 8 times more common in men than women. Oesophageal cancer has a low 5 year survival 
rate of only 10% and is also one of the least studied cancers (Ballo and Millikan, 2015). 
Oesophageal cancers have poor prognosis with early local invasion to the lymphatic system. 
Early symptoms of oesophageal cancer (weight loss and dysphagia) generally go unnoticed, 
hence, oesophageal cancer is generally diagnosed at an advanced stage. Other symptoms 
include retrosternal pains, food/saliva regurgitation, blood loss causing anaemia, coughing and 
pneumonias (Ballo and Millikan, 2015).  
The two main types of oesophageal cancer include adenocarcinoma from Barrett’s oesophagus 
and squamous cell carcinoma (SCC). The risk factors for SCC include smoking, foods 
containing N-nitroso compounds, alcohol abuse, achalasia, drinking hot liquids, history of 
corrosive childhood oesophageal injury and tylosis. A risk factor for adenocarcinoma is 
intestinal metaplasia due to established gastroesophageal reflux disease (GERD). The 
oesophagus is highly susceptible to the effects of toxins due to maximum exposure via ingestion 
of toxin-contaminated foodstuffs (Ballo and Millikan, 2015).  
Oesophageal cancer is treated mainly via surgical removal. Other treatments include: 
neoadjuvant (preoperative) chemotherapy which involves shrinkage of the primary tumour and 
killing of the micrometastases in local and systemic nodes; radiation therapy; and palliative 
therapy to improve symptoms and comfort while reducing illness and hospital stay (laser 
therapy, stenting, oesophageal dilations and brachytherapy) (Shahbaz Sarwar et al., 2010, Ballo 
and Millikan, 2015). 
 
1.3.1.2 SNO cell line 
SNO (spindle-shaped N-cadherin (+) CD45 (-) osteoblastic) cells are human oesophageal 
epithelial carcinoma cells. The SNO cell line was initially derived from a well-differentiated 
squamous cell carcinoma (6.5 cm in length, metastatic to lymph nodes) explanted from a 62-
year old Zulu African male (Patient S. N.) in July 1972. SNO cells are non-keratinising cells 
that express a variety of apoptotic genes which code for many proteins. These cells grow as an 
adherent monolayer and rapidly invade surrounding tissue since the oesophageal outer surface 
lacks a serous membrane. Hence, SNO cells are suitable as a transfection host and a good model 







At least 300 mycotoxins exist in nature and are naturally produced as secondary metabolites by 
fungi. The most economically significant types of fungi that produce mycotoxins are Fusarium, 
Penicillium and Aspergillus. Mycotoxins are low molecular mass molecules that can be highly 
toxic even at very low concentrations. Some can interfere with membrane integrity, as this 
cytotoxic effect aids their mycological pathogenicity, or for self-defence purposes (Surai et al., 
2008).  
The toxicity of mycotoxins in humans depends on various factors, including the membrane-
active properties, type, level and duration of exposure of the mycotoxin. Host factors such as 
age, gender, health, dietary status and genetics of exposed individual; and other mycotoxin 
interactions also determine toxicity (Omar, 2013). Different mycotoxins may affect various 
cellular processes, e.g. nucleic acid synthesis, protein synthesis, lipid synthesis, DNA adduct 
formation, pro-apoptotic activity and alteration of gene expression. Essentially, molecular 
mechanisms of mycotoxin associated toxicity include alteration of membrane structure and 
induction of apoptosis, oxidative stress and lipid peroxidation which result in functional 
alterations in growth, development and reproduction (Surai et al., 2008).  
A major mode of mycotoxin toxicity is via ingestion of agricultural produce that has been 
contaminated with fungi producing mycotoxins (Pal et al., 2015). Mycotoxin contamination of 
grain is influenced by moisture levels (ought to be <15%) and stress due to drought. Fusarium 
mycotoxins contaminate most cereal grains (Surai et al., 2008). 
 
1.3.2.1 Fusaric acid 
Fusaric acid (5-n-butyl-pyridine-2-carboxylic acid) (FA) is a mycotoxin produced by Fusarium 
heterosporum and other Fusarium species. This mycotoxin was initially discovered by Yabuta 
et al. (Yabuta et al., 1937) as a low to moderately toxic mycotoxin that is found in maize, 
wheat, oats, rye and barley. FA is synergistic with other mycotoxins including Fumonisin B1, 
and can enhance the global toxic effects of other mycotoxins. FA was reported to have a mean 
concentration of 643 µg/kg in feed samples (Streit et al., 2013) and may perhaps be amongst the 
most extensively distributed mycotoxins produced by Fusarium species in agricultural 
commodities (Bacon et al., 1996). 
Fusaric acid is a metabolite of picolinic acid (PA), which is catabolised from L-tryptophan and 
contains a pyridine ring. This feature allows PA to affect the synthesis of nicotinamide adenine 
dinucleotide (NAD+) since PA is an isomer of nicotinic acid, and allows it to chelate divalent 
metal cations such as zinc (Zn2+), nickel (Ni2+), lead (Pb2+) and cadmium (Cd2+). The pyridine 
ring along with its substituent carboxyl group is also present in FA, and maintains its chelation 
properties. However, FA contains a lipophilic butyl aliphatic side chain in position five which 
PA lacks (Fernández-Pol, 1998, Ogata et al., 2001). 
Picolinic acid synthesis occurs via the kynurenine pathway which involves the catabolism of 
tryptophan to produce NAD, PA and kynurenic acid. PA elicits several effects in the human 
body. It has especially been involved in antimicrobial activity and improved immune function. 
PA has shown to positively affect normal, healthy cells, and induce apoptosis of microbacterial-
infected cells, reduce viral replication and has also been effective in killing lymphoma cells in 
rats. Cytotoxicity of PA is attributable to its activity as a chelating agent (Fernández-Pol, 1998, 





Since FA is a weak acid, it functions as a proton (H+) carrier and can affect the polarity of 
membranes by dissipating the mt membrane proton gradient and uncoupling the electron 
transport chain from oxidative phosphorylation. The effect of FA on mt membranes in particular 
compromises ATP production. FA inhibits succinate dehydrogenase and α-ketoglutarate 
dehydrogenase in the Krebs TCA cycle, which require H+ ions to form FADH2 and NADH, 
respectively. It also inhibits oxidative phosphorylation via direct inhibition of ATPase or via 
inhibition of the ADP/ATP transport system. In this way, FA inhibits mt energy metabolism, 
leading to reduced cell viability and cell death. Since FA inhibits mt energy metabolism, all cell 
processes that are dependent on ATP are compromised (Telles-Pupulin et al., 1998). 
 
Figure 1.2: Fusaric Acid. Molecular structure of FA showing the butyl group (4C), pyridine 
ring (C5H5N) and carboxyl group (COOH) (Prepared by Author). 
	  
The pyridine ring of FA (Figure 1.2) allows it to form chelate rings by sequestering divalent 
metal cations between the N atom of the pyridine ring and the carboxyl radical in the α-position, 
creating a five-membered direct link (Gäumann, 1958). The pyridine ring of FA also inhibits 
oxidative phosphorylation (Bachmann, 1956) and induces DNA damage via chelation of 
divalent metal cations from catalytic DNA-associated metalloproteins, preventing DNA repair 
and synthesis (Stack et al., 2004). The n-butyl aliphatic side chain in the β-position of FA 
accentuates its lipophilic properties, increasing its permeability to allow effortless penetration 
through cell membranes (Fernández-Pol, 1998). The lipophilic tail of FA also impairs 
cytochrome c oxidase activity, thereby uncoupling the electron transport chain (ETC) from ATP 
synthesis (Gäumann, 1958). 
Many of the metal cations chelated by FA are cofactors of enzymes required for normal cellular 
processes, FA thereby inhibits the functioning of certain enzymes via deprivation of these 
cations (Fernández-Pol, 1998). Furthermore, divalent cations contribute to membrane integrity 
by stabilising the ordered state of membranes. Divalent cations react with negatively charged 
phospholipids in membranes which are essential for natural processes such as signal 
transduction (Träuble and Eibl, 1974). Divalent ions also inhibit permeability changes in 
membranes by blocking leakage at the site of lesion formation subsequent to binding of toxins 
to cells. Calcium (Ca2+) and Zn2+ are heavily involved in this inhibition and are known 
membrane protective agents. FA thereby disrupts membranes and prevents normal processes 
from occurring by chelating divalent cations (Bashford et al., 1986).  
FA has many primary and secondary effects in the human host. FA inhibits tyrosine 
hydroxylase and dopamine β-hydroxylase, which result in elevated levels of serum melatonin, 
tyrosine, dopamine and 5-hydroxytrypamine. FA induces peripheral arteriolar dilation which 







1.3.3 Oxidative stress 
Oxidative stress was first described by Sies as “an imbalance between oxidants and antioxidants 
in favour of the oxidants, leading to a disruption of redox signalling and control and/or 
molecular damage” (Sies, 1985). Oxidants (a class of free radicals), are highly reactive species 
which contain one or more unpaired valence electrons and are capable of independent existence. 
The free valence electrons “steal” their electrons from neighbouring molecules, causing 
oxidation to cellular macromolecules. Oxidation causes structural and functional alterations to 
nucleic acids, proteins, carbohydrates and DNA which result in lipid peroxidation, oxidation of 
amino acids in proteins, DNA mutations and loss of enzyme function via oxidation of cofactors. 
Free radicals comprise of ROS and reactive nitrogen species (RNS). Normal, healthy cells 
neutralise toxic levels of ROS through decomposition via antioxidants (Kelly, 2003, Ježek and 
Hlavatá, 2005).  
 
1.3.3.1 Reactive oxygen species (ROS) 
ROS are chemically reactive molecules or ions that form due to incomplete one-electron 
reduction of oxygen (Pan et al., 2009). Intermediates of ROS include singlet oxygen, hydrogen 
peroxide (H2O2), hypochlorous acid (HOCl), fatty acid hydroperoxides, reactive aldehydes, 
hydroperoxyl radical (HO2●), primary superoxide anion radical (O2●-), hydroxyl radical (●OH), 
peroxyl radical (RO2●), carbonate radical (CO3●-) and alkoxyl radical (RO●) (Ježek and Hlavatá, 
2005, Pan et al., 2009).  
ROS are natural by-products of various natural cellular processes, especially respiration in 
mitochondria. They are necessary for normal physiological functions to occur, such as 
apoptosis, cell signalling and cellular immunity (Ježek and Hlavatá, 2005). Other processes 
include one-carbon oxygen reduction during the process of aerobic respiration which yield 
hydroxyl and superoxide radicals; activated phagocytes produce HOCl and O2●- (oxidative 
burst), certain cells and vascular endothelium produce nitric oxide. ROS are also by-products of 
biochemical processes such as the arachidonic acid cascade activation and catecholamine 
oxidation produce electrons which are capable of reducing molecular oxygen to superoxide 
anion (Betteridge, 2000). Exogenous sources of ROS include pollutants, smoke, drugs, toxins 
and radiation, like gamma rays, which form hydroxyl radicals from the separation of water 
(Betteridge, 2000, Pan et al., 2009). 
Free radical attack on lipid components of the cell leads to lipid peroxidation (oxidation of 
polyunsaturated fatty acids in lipids). Some free radicals, such as the hydroxyl radical, can react 
with a hydrogen atom (H) from the methylene bridge (CH2) of fatty acids, resulting in a carbon 
with an unpaired electron (CH). Polyunsaturated fatty acids are highly susceptible to free radical 
attack due to the presence of the double bond in the methylene bridge which weakens the C-H 
bond at the neighbouring carbon atom. The resultant radical becomes rearranged forming a 
conjugated diene, which has the capacity to conjugate with oxygen to produce a peroxyl radical. 
This peroxyl radical forms a free radical chain reaction mechanism by interacting with an 
adjacent H. This reaction goes on until substrate consumption occurs, or termination via an 
antioxidant like vitamin E which breaks the chain reaction. Extensive lipid peroxidation of cell 
membranes alters membrane fluidity, causes increased permeability, decreased membrane 
potential, and ultimately rupture of the membrane (Betteridge, 2000). 
Free radicals oxidise DNA to form single-/double-strand breaks and mutations (Betteridge, 





hydroxyl radical is produced near DNA, it interacts with nucleotide bases of DNA causing the 
addition of new DNA bases resulting in variation of oxidation products, for example, guanine is 
converted to C8-hydroxyguanine (8-OHGua) or its  oxidised nucleoside form 7,8-dihydro-8-
oxo-2`-deoxyguanosine (8-oxodG) (Kasai, 1997). Another product of oxidative DNA damage is 
thymine glycol (5,6-dihydroxydihydrothymine), an oxidative mutagen produced via ionising 
radiation or chemical oxidation (Cathcart et al., 1984). Along with nuclear DNA, mt DNA is 
highly susceptible to oxidative damage by free radicals. This is due to the close proximity of mt 
DNA to the ETC in the mitochondria since ROS are abundantly produced in the ETC, and mt 
DNA contain fewer introns and lack histones which serve to protect against and repair oxidative 
base lesions (Circu and Aw, 2010). Along with reduced protection, reduced fidelity of 
replication by mt-specific DNA polymerase γ contribute to faster accumulation of mt DNA 
mutations than nuclear DNA (Qian et al., 2014). 
Free radicals cause protein damage via crosslinking or conjugation of carbonyl groups to amino 
acid residues to from carbonyl derivatives or fragmentation. Carbonyl derivatives make the 
protein prone to proteolysis (Dalle-Donne et al., 2003). The R groups of amino acid residues of 
proteins, especially methionine and cysteine residues are susceptible to ROS/RNS oxidation 
(Stadtman, 2004).  
 
1.3.3.2 Antioxidant response 
Due to the potential of ROS-associated toxicity in tissue, cells have developed protective 
antioxidant defence mechanisms. Antioxidants were described by Gutteridge (1995) as “any 
substance that, when present at low concentrations, compared with those of the oxidisable 
substrate, considerably delays or inhibits oxidation of the substrate” (Gutteridge, 1995). 
Antioxidant defences are categorised as cellular (catalase (CAT), dismutase and peroxidase 
enzymes), extracellular and membrane mechanisms (Gutteridge, 1995). Superoxide dismutase 
(SOD) (localised in the cytoplasm contains copper (Cu) and Zn, whilst SOD localised in the 
mitochondria contains manganese) catalyses the detoxification of superoxide radical to 
hydrogen peroxide and oxygen (Gutteridge, 1995).  
2O2●- + 2H+ à H2O2 + O2 
This hydrogen peroxide is a weak oxidant which has the ability to diffuse rapidly across 
membranes, and is capable of being converted to hydroxyl radicals in the presence of transition 
metal ions (Gutteridge, 1995). 
Fe2+   +   H2O2   à   Fe3+   +   ●OH   + OH- 
Hydrogen peroxide can be detoxified by two antioxidant systems, glutathione peroxidase (GPx) 
and CAT. GPx is found in the cytoplasm and mitochondria and detoxifies hydrogen peroxide by 
oxidising GSH (Gutteridge, 1995). 
      GPx      
   2GSH   +   H2O2   à   GSSG   +   2H2O 
High concentrations of CAT which are found in peroxisomes in several tissues can detoxify 
hydrogen peroxide (Gutteridge, 1995). 





Non-enzymatic antioxidants such as β-carotene, coenzyme Q and α-tocopherol (vitamin E) are 
highly effective within the lipid components of cell membranes (Gutteridge, 1995). Other non-
enzymatic antioxidants include ascorbic acid (vitamin C), GSH and flavonoids. GSH (L-γ-
glutamyl-L-cysteinyl-glycine) is an important thiol antioxidant and cellular redox buffer. GSH 
is the reduced form, while GSSG (glutathione disulphide) is the oxidised form (Gutteridge, 
1995). 
              GPx      
    ROOH   +   2GSH   à   2ROH   +   GSSG 
GSH is localised in the cytoplasm, nuclei and mitochondria. Synthesis of GSH occurs in the 
cytoplasm via glutamate–cysteine ligase and glutathione synthetase, and it is transported into 
the mitochondria via inner membrane carrier proteins, dicarboxylate and 2-oxoglutarate carrier 
proteins, against a concentration gradient. The GSH/GSSG ratio can be used to measure the 
level of oxidative stress in an organism (Circu and Aw, 2008).  
The major protective roles of GSH against oxidative stress include: (a) GSH serves as a cofactor 
for many detoxifying enzymes against free radicals, such as GPx and GSH transferase; (b) GSH 
contributes to the transport of amino acids through the cell membrane; (c) GSH directly 
scavenges singlet oxygen and hydroxyl radicals - GPx catalyses detoxification of lipid 
peroxides and hydrogen peroxide; (d) GSH can regenerate inactive vitamins C and E back to 
their active forms - GSH reduces tocopherol radical of Vitamin E to ascorbic acid (Masella et 
al., 2005). 
 
1.3.3.3 Mitochondrial ROS 
The mitochondrion is the principle source of cellular energy (ATP) and is the metabolic hub of 
the cell. However, it is also the major source of endogenous ROS. A proton (H+) 
electrochemical potential gradient exists within the inner mt membrane (IMM) due to the flow 
of electrons from reducing equivalents, such as NADH and FADH2, through complexes of the 
ETC and is used to drive ATP synthesis. Enzymatic electron transport along the ETC coupled 
with a proton gradient across the IMM which drives the ATPase to generate ATP is termed 
oxidative phosphorylation. Oxidative phosphorylation does not have the capacity to contain 
electron flow specifically for ATP production, hence, some electrons escape the ETC and 
interact with oxygen to produce O2●- (Ježek and Hlavatá, 2005). 
As mentioned, during aerobic metabolism in the mitochondria, superoxide anion is produced in 
specific sites in complexes I, II and III from premature one-electron reduction of oxygen and is 
catalysed by SOD to form hydrogen peroxide in the mitochondria and cytoplasm (Figure 1.3) 






Figure 1.3: Mitochondrial ETC generates ROS. Electron transfer between complexes within the 
ETC give off ROS as a by-product (Prepared by Author). 
	  
Complexes I and II of the mitochondria reduce coenzyme Q (CoQ) using electrons donated 
from NADH and FADH2. CoQ transports the electrons to complex III. The electrons are then 
transferred from complex III to cytochrome c. Cytochrome c donates electrons to complex IV to 
allow the reduction of molecular oxygen to water. The flow of electrons between complexes I, 
III, and IV generate a H+ electrochemical potential gradient, which produces free energy that is 
used to phosphorylate ADP at ATP synthase. Superoxide is produced at complexes I, II, and III 
due to incomplete reduction of oxygen. Complexes I and II generate superoxide specifically into 
the mt matrix, while complex III generates superoxide into the matrix and intermembrane space 
(IMS) (Figure 1.3) (Hamanaka and Chandel, 2010). 
	  
1.3.4 Apoptosis 
The term “apoptosis” was first used by Kerr et al. to describe programmed cell death due to 
intrinsically regulated mechanism for suicide (Kerr et al., 1972). Apoptosis is essential for 
maintenance of tissue homeostasis, immune function, growth and development. It allows for the 
rapid removal of redundant, senescent, damaged, genetically mutated, or virus infected cells. 
For example, histogenic cell death of neurons during brain development, phylogenic cell death 
of the tail of the vertebra during foetal development, morphogenic cell death of mesenchyme 
between fingers and toes and programmed cell death of damaged precancerous cells (Fan et al., 
2005).  
Apoptosis is characterised by several distinct and sequential morphological features which are 
due to the activation of caspases (cysteine aspartate proteases). These include cell shrinkage, 
internucleosomal DNA fragmentation, nuclear and cytoplasmic condensation, membrane 
“blebbing”, apoptotic body formation, rapid phagocytosis and degradation by adjacent cells 
(Figure 1.4). Even though fragmentation and condensation occur, the apoptotic bodies that form 
are bound by intact membranes enclosing fragments of functional cellular components of 






Figure 1.4: Series of events that occur throughout apoptosis. Cells separate from each other and 
undergo a series of events involving cellular shrinkage and fragmentation leading to 
phagocytosis of apoptotic bodies and lysosomal digestion (Image adapted from Kerr et al., 
1972). 
	  
Another type of cell death, called necrosis, has distinct morphological characteristics different 
to that of apoptosis (Edinger and Thompson, 2004). There are several variations between the 






Table 1.1: Distinction between morphological and biochemical characteristics of apoptosis vs 
necrosis (Adapted from Edinger and Thompson, 2004). 
Apoptosis Necrosis 
Affects scattered, individual cells Affects neighbouring cells, hence tissues and 
organs 
Physiological response to cell suicide 
mechanism which requires ATP (regulated) 
Pathological response to physical damage or 
toxic insult which resulted in serious 
depletion of ATP 
Organised fragmentation of chromosomal 
DNA into 200 base pair fragments 
Random degradation of DNA 
Cytoplasmic condensation Vacuolation of cytoplasm 
Membrane blebbing and apoptotic body 
formation with maintained cell membrane 
integrity 
Membrane blebbing followed disintegration 
of cell membrane 
Absence of inflammation around lysed cell 
since phagocytes recognise and remove 
apoptotic bodies 
Induction of inflammation around lysed cell 
due to leakage of pro-inflammatory 
molecules and cellular components. 
Cell shrinkage due to extrusion of water Cell swelling due to swelling of organs 
(cellular oedema) 
Apoptosis can occur via the extrinsic or intrinsic pathway, the endpoint of which is the 
activation of several proteases and endonucleases to degrade specific cellular proteins and other 
constituents. Apoptosis can also occur via caspase-independent pathways which don’t require 
caspase activity (Fan et al., 2005). 
 
1.3.4.1 Caspases 
Caspases belong to the interleukin-1β-converting enzyme family of proteases. All caspases have 
consistent properties: cysteine proteases that are specific to aspartate residues; exist as inactive 
precursors (zymogens) called pro-caspases; have a conservative active site consisting of five 
residues (QACXG); caspase activation requires the extremely diverse structure of the N-
terminal in pro-caspases; all caspases have the capacity to auto-activate and activate other 
caspases (Fan et al., 2005). 
Caspases are involved in the caspase-cascade system and are regulated by numerous molecules, 
for example, B-cell lymphoma/leukemia-2 (Bcl-2) family proteins, inhibitor of apoptosis (IAP) 
proteins, Ca2+ and calpain. Caspases are categorised according to their involvement in inducing, 
transducing and amplifying intracellular apoptotic signals and according to their substrate 
specificity (Fan et al., 2005). The first subfamily of caspases include the initiator caspases, 
caspase-2, -8, -9 and -10. Caspase-2, -8 and -10 are involved in the initiation of the extrinsic 
apoptotic pathway. Caspase-9 is involved in the induction of the intrinsic apoptotic pathway 
(Fan et al., 2005).  
 
1.3.4.2 Intrinsic apoptotic pathway: mitochondrial-mediated 
The intrinsic apoptotic pathway, also known as the mt pathway, can be triggered by various 





withdrawal, toxins, ceramide, DNA damage, endoplasmic reticulum stress, ultraviolet and γ-
irradiation, and growth factor deprivation trigger the intrinsic pathway. This occurs via Bax 
(Bcl-2-associated X) activation, a pro-apoptotic protein of the bcl-2 superfamily, which form 
oligomers on the outer mt membrane (OMM) resulting in altered mt polarity, permeability and 
mt dysfunction. The anti-apoptotic proteins of the Bcl-2 superfamily, Bcl-2 or Bcl-XL, have the 
capacity to inhibit the pro-apoptotic activity of Bak and Bax. Dysfunction of the mitochondrion 
results in the release of several apoptotic proteins stored within the IMS of mitochondria into 
the cytoplasm, such as, second mitochondria derived activator of caspases/direct IAP binding 
protein with low pI (Smac/DIABLO) and cytochrome c. Smac/DIABLO allows for caspase 
activation by binding and inhibiting the activity of XIAP. Cytochrome c binds to the adaptor 
protein, adaptor apoptosis associated factor 1 (Apaf-1). Cytochrome c-bound Apaf-1 recruits 
pro-caspase-9 (inactive) to form an ATP-requiring apoptosome, which cleaves and activates 
pro-caspase-9 to produce active initiator caspase-9. Thereafter, caspase-9 cleaves and activates 
pro-caspase-3, -6 and -7 to produce effector caspases-3, -6 and -7 which are accountable for 
cellular substrate degradation, such as PARP-1 (Figure 1.5) (Green and Reed, 1998, Green and 
Kroemer, 2004). 
 
Figure 1.5: Intrinsic apoptotic pathway. Mitochondrial-mediated cell death pathway triggered 
by intracellular stressors which result in the oligomerisation of Bax and release of pro-apoptotic 
proteins from the mitochondria. These events trigger a caspase-cascade which ultimately result 






1.3.4.3 Extrinsic apoptotic pathway: death receptor-mediated 
The extrinsic apoptotic pathway is initiated at the cell membrane subsequent to the engagement 
of death receptors (e.g. tumour necrosis factor related apoptosis inducing ligand receptors 1 and 
2 (TRAIL-R1 and TRAIL-R2), Fas/CD95 and tumour necrosis factor receptor 1 (TNF-R1), and 
by their associated ligands (TRAIL, Fas ligand (FasL)/CD95L and TNF-α). Binding of the 
receptor to the ligand induces receptor oligomerisation and adapter protein (TNF-R1 associated 
death domain protein (TRADD), Fas associated protein with death domain (FADD)) 
recruitment. This event leads to binding of the inactive pro-enzymes, initiator pro-caspase-8 and 
-10, to the intracellular domain of the death receptor to create a complex called death inducing 
signalling complex (DISC). Activated caspases at the DISC produce signals (due to the close 
proximity of a number of procaspase proteins) which lead to cell death by self-processing. 
Initiator caspases (active) can directly cleave and activate downstream effector caspases, or 
participate in the intrinsic apoptotic pathway. This can occur via cleavage and activation of Bid, 
the BH3 only protein, to form t-Bid (Figure 1.6) (Ashkenazi and Dixit, 1998). 
 
Figure 1.6: Extrinsic apoptotic pathway. The death receptor-mediated pathway involves the 
engagement of death receptors (e.g., Fas, TNFR1 and TRAIL-R) by their associated ligands 
(e.g., FasL, TNF and TRAIL), which induce recruitment of adapter proteins, procaspase-8 and -
10 at the intracellular domain of the receptor to form a DISC. The signal generated at the DISC 
by activated caspases results in cell death (Image adapted from Guicciardi and Gores, 2005). 
	  
1.3.4.4 Bcl-2 family of proteins 
The Bcl-2 family proteins regulate apoptosis by regulating the OMM. Based on Bcl-2 homology 
(BH) domains and protein function, Bcl-2 family proteins are divided into anti- and pro-
apoptotic proteins. Anti-apoptotic proteins have BH1, BH2, BH3 and BH4 domains, e.g. Bcl-xL 
and Bcl-2. Pro-apoptotic proteins are further subdivided into two groups: proteins containing 
BH1, BH2 and BH3 domains, e.g. Bax and Bak; proteins containing only BH3 domains, e.g. 
Bad and Bin. There is also an exceptional pro-apoptotic protein called Bcl-xS which contains 





Bax (21 kDa protein) is a naturally occurring monomer localised in the cytoplasm and has also 
been shown to be localised on the OMM. Upon apoptotic stimulus, a change in pH or Bid 
interaction causes Bax to change its conformation and become a pro-apoptotic oligomer which 
translocated to the OMM. This oligomerisation of Bax can cause cytochrome c release from 
mitochondria into the cytoplasm. This occurs via interaction with voltage-dependent anion 
channels (VDACs) to from large pores in the OMM and increasing its permeability (Figure 1.7). 
The conformational change in Bax exposes its N-terminal domain and C-terminal 
transmembrane domain. The C-terminal sequence functions as a signal anchor which targets 
Bcl-2 to the mitochondria, hence, in response to cellular stress, Bax changes its conformation 
and lodges into the OMM, where it forms channels and becomes permeable to release 
cytochrome c and other pro-apoptotic proteins (Gross et al., 1998, Desagher et al., 1999, Harris 
and Thompson, 2000). 
 
Figure 1.7: Bax oligomerises to allow cytochrome c release from mitochondria. Increased pH 
or Bid interactions due to apoptotic stimulus lead to oligomerisation of Bax to form channels in 
the OMM (Prepared by Author). 
	  
Bcl-2 is localised in the membranes of the mitochondria, nucleus and endoplasmic reticulum 
(ER). Bax and Bcl-2 are similar proteins with contrasting effects on the living state of cells, 
since Bax accelerates apoptosis while Bcl-2 prolongs cell survival (Reed, 1994). Bcl-2 regulates 
apoptosis by inhibiting translocation of Bax to the mitochondria, and also thereby inhibits all 
downstream effects of Bax, such as mt membrane depolarisation induced by Bax, and 
cytochrome c release. Bcl-2 may displace Bax by sequestering the site at which Bax inserts 
itself into the OMM. As mentioned, the exposure of the C-terminal of Bax causes Bcl-2 to 
target the mitochondria. Bax translocation may be inhibited by Bcl-2 by binding to this C-
terminal (Murphy et al., 2000). 
 
1.3.4.5 Mitochondrial membrane potential & ATP production 
The principal function of mitochondria is the production of ATP via oxidative phosphorylation 





and elimination, cellular Ca2+ content, metabolite anabolism and catabolism, and translocation 
of organelles. In healthy and functional mitochondria, energy is transduced within the mt matrix 
via an ATPase complex embedded in the IMM membrane which requires protons (H+) 
generated from the ETC also within the IMM (Figure 1.8). This energy is stored as an 
electronegative chemical gradient across the mt membrane, allowing for the retention of 
membrane potential which is necessary for ATP production in the inner mt membrane (IMM). 
The membrane is regarded as polarised. Dysfunctional mitochondria have collapsed membrane 
potentials due to a disrupted chemical gradient, which results in depolarisation of the mt 
membrane. Since ATP production is necessary for cell survival and a maintained mt membrane 
potential is necessary for ATP synthesis, mt depolarisation is regarded as a pro-apoptotic event 
(Brand and Nicholls, 2011). 
 
Figure 1.8: ATP synthase complex in IMM. ATP is synthesised in the mt matrix driven by a 
proton (H+) gradient (Prepared by Author). 
	  
1.3.4.6 Inhibitor of apoptosis proteins and Smac/DIABLO 
Inhibitor of apoptosis (IAP) proteins are anti-apoptotic proteins that were initially discovered in 
1993 due to their capacity to suppress cell death (Crook et al., 1993). IAP proteins belong to a 
family of five proteins associated with immunity, migration, cell cycle, cell death and 
inflammation. These proteins are characterised based on the presence of baculovirus IAP 
repeats (BIR domains) and contain Zn-finger-like motifs. Human IAP family of proteins 
comprise of eight members: normal-molecular-weight IAP (NIAP) which contains BIRC1; 
cellular IAP proteins (c-IAPs) form part of the TNFR2 complex, c-IAP1 contains BIRC2 and c-
IAP2 contains BIRC3; X-chromosome-linked IAP (XIAP) contains BIRC4; survivin contains 
BIRC5; Apollon/Bruce contains BIRC6; livin or ML-IAP contains BIRC7 and ILP-2 contains 
BIRC8. The IAP proteins which directly regulate apoptosis include XIAP, c-IAP1, c-IAP2 and 
ML-IAP (de Almagro and Vucic, 2012). 
The extrinsic apoptotic pathway is regulated by c-IAP1 and c-IAP2 via ubiquitin ligation. The 
intrinsic pathway is regulated by XIAP which binds and inhibits caspase-3/7 and -9 activities 
(Figure 1.9). XIAP, on the other hand, is inhibited by Smac/DIABLO and HtrA2 (serine 
protease with an IAP-binding motif (IBM), AVPS) (de Almagro and Vucic, 2012). Regions on 
the N-terminal side of BIRC2 of XIAP (Ala-Thr-Pro-Phe) interact with the catalytic site of the 






Figure 1.9: XIAP inhibits caspase-3/7 and caspase -9. The sequence between the BIR1 and 
BIR2 domains sequester the catalytic site of caspase-3/7, thereby inhibiting substrate entry. The 
BIR2 domain interacts with the exposed IBM of active caspase-3/7 (presented in green). Active 
caspase-9 (with an exposed IBM) binds to BIR3 of XIAP, inhibiting caspase-9 dimerisation 
required for caspase-9 activity (Prepared by Author). 
	  
Smac/DIABLO is an intracellular, pro-apoptotic IAP protein inhibitor which is localised in the 
IMS of the mitochondria and released into the cytoplasm during apoptosis. Smac/DIABLO is a 
dimer which competitively binds to IAP proteins, namely, c-IAP1, c-IAP2, XIAP and survivin, 
to prevent binding and inhibition of caspase-3/7 and -9 (Chai et al., 2000). Smac/DIABLO 
binds BIRC2 and BIRC3 (simultaneously) on the N-terminal IBM containing the first four 
amino acid residues, AVPI (Ala–Val–Pro–Ile), on XIAP (Vaux and Silke, 2003, de Almagro 
and Vucic, 2012). Smac/DIABLO is initially synthesised as a precursor molecule containing 
239 amino acid residues. The N terminal which contains 55 residues is a mt targeting sequence, 
which is degraded subsequent to import. Mature Smac/DIABLO only consists of 184 amino 
acid residues and naturally exists as an oligomer. The relationship between Smac/DIABLO and 
IAP proteins play an important role in the tight regulation of apoptosis (Chai et al., 2000).  
 
1.3.4.7 Poly (ADP-ribose) polymerase-1 activity 
PARP-1 is a DNA-binding Zn-finger endonuclease that catalyses the degradation of 
internucleosomal DNA and is associated with the biochemical alterations that occur during 
apoptosis. PARP-1 is a 113 kDa protein and has 6 domains, which when cleaved, forms an 89 
kDa and a 24 kDa fragment. The 89 kDa fragment is relatively stable containing the complete 
and intact carboxyl terminus; it lacks the Zn-finger domains (Zn1, 2 and 3) but contains the 
catalytic domain (helical subdomain and ADP-ribosyl transferases) and automodification 
domains (BRCA1-terminus). This fragment is covalently altered by a derivative of NAD+ which 
is degraded by a poly (ADP-ribose)-specific enzyme and is responsible for NAD+ consumption 
in late stage apoptosis. The 24 kDa fragment contains the Zn-finger DNA-binding domain and 
the amino terminus. Chelation of the Zn-fingers would desensitise the 89 kDa fragment to 
activation by nicked DNA, preventing DNA repair (Kaufmann et al., 1993, Langelier et al., 
2012). 
In response to DNA damage (DNA single or double stranded breaks), PARP-1 converts NAD+ 
to nicotinamide as well as protein-linked ADP-ribose polymers, and catalyses the transfer of 
these polymers from NAD+ to several molecules such as chromatin. PARP-1 is rather inactive 
in normal, healthy cells until it becomes activated by single or double stranded DNA breaks. 
When PARP-1 recognises interruptions in DNA strands, it binds to the damaged DNA via one 





Thereafter, PARP-1 undergoes conformational changes and is activated. This activation of 
PARP-1 consumes NAD+ which is consistent with cellular consumption of NAD+ during 
apoptosis. Poly (ADP-ribosyl)ation of several nuclear proteins is catalysed by activated PARP-
1, which aids protein release from damaged strands of DNA and allows DNA repair enzymes to 
interact with single strand DNA disruptions that are inhibited by unmodified PARP-1 
(Kaufmann et al., 1993). 
PARP-1 is capable of interacting with RNA to inhibit transcription. The translocation of AIF 
from the mitochondrion to the nucleus is dependent on PARP-1. Deficiencies of PARP-1 result 
in aneuploidy and chromosomal instability since more and more chromosomes pair up. This 
means that poly (ADP-ribosyl)ation maintains genome integrity (Kaufmann et al., 1993). 
The protease responsible for PARP-1 cleavage is caspase-3/7. Caspase-3/7 recognises and 
cleaves a tetrapeptide carboxyl cleavage site on PARP-1, Asp-Glu-Val-Asp (DEVD), located 
between Gly215 and Asp214, to produce 24- and 89-kDa polypeptides (Germain et al., 1999, 
Herceg and Wang, 1999). Zinc is essential to allow for the binding of PARP-1 to DNA strand 
breaks as Zn inhibits PARP-1 cleavage. This is achieved by Zn inhibition of the catalytic 
function of caspase 3 by interaction with either or both of the conserved sites, Cys-285 and His-
237. This is another mechanism by which Zn chelation would allow for PARP-1 cleavage by 






Materials and Methods 
2.1 Materials 
SNO cells were purchased from Highveld Biologicals (Johannesburg, South Africa (SA)). Cell 
culture reagents were purchased from Lonza Biotechnology (Basel, Switzerland). Western blot 
reagents were obtained from Bio-Rad (Hercules, CA, United States of America (USA)) and all 
antibodies sourced from Cell Signalling Technology. All other reagents were obtained from 
Merck (Darmstadt, Germany) unless otherwise stated. 
 
2.2 Fusaric acid (FA) preparation 
FA (Gibberella fujikuroi) (F6513) was obtained from Sigma Aldrich (St Louis, MO, USA). A 
stock solution (20 mg/ml) was prepared in 0.1 M phosphate-buffered saline (PBS) and diluted to 
1 mg/ml stocks prior to each treatment for biochemical assays. Stock solutions were stored at 
4°C. 
 
2.3 Cell culture 
SNO cells were cultured (37°C, 5% CO2) in sterile 25 cm3 cell culture flasks in complete culture 
medium (CCM) comprising of Eagle’s minimum essential medium (EMEM) supplemented with 
10% fetal calf serum, 1% L-glutamine and 1% penicillin-streptomycin-fungizone until 90% 
confluency (Wilson and Walker, 2010). The 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, or methylthiazol tetrazolium (MTT) assay was conducted to 
determine an IC50 value (concentration that produced half the maximum inhibition) for FA; 
which was used in all subsequent assays. 
 
2.4. Methylthiazol tetrazolium (MTT) assay 
2.4.1 Introduction 
The MTT salt is a water-soluble tetrazolium yellow dye which is reduced by metabolically 
active cells to a water-insoluble purple formazan product (Figure 2.1). As only cells with 
functional mitochondria can cleave the tetrazolium ring, this assay is used to determine cell 
viability. Reducing enzymes that catalyse the transfer of electrons to an oxidant compound in 
the presence of reducing equivalents - flavin adenine dinucleotide (FADH2) and nicotinamide 
adenine dinucleotide (NADH); catalyse the reaction. Both FADH2 and NADH are derived from 
the tricarboxylic acid (TCA) cycle (Figure 2.2). The intensity of the formazan product is 
therefore, directly proportional to cellular metabolic activity which can be measured using a 






Figure 2.1: The purple formazan product following the reduction of the yellow tetrazolium 










The cytotoxicity of FA on SNO cells was determined via the colorimetric MTT assay. SNO 
cells were seeded into a 96-well microtitre plate at an inoculation density of 15,000 cells/well in 
triplicate. Cells were incubated with a range of FA concentrations (0; 25; 50; 100; 250; 350 and 
500 µg/ml) at 37°C for 24 h. Thereafter, the cells were incubated with MTT salt solution (5 
mg/ml in 0.1 M PBS) and CCM at 37°C for 4 h. The supernatants were then aspirated and 100 
µl dimethyl sulphoxide (DMSO) was added to each well and incubated at 37°C for 1 h to 
solubilise the formazan crystals. The optical density (OD) was measured using an enzyme-
linked immunosorbent assay (ELISA) plate reader (Bio-Tek µQuant) at 570/690 nm. The 
percentage cell viability of the samples (refer to equation below) and a concentration-response 
curve was plotted using GraphPad Prism v5.0 software relative to the control. The concentration 
of FA that produced half the maximum inhibition (IC50) had been calculated via linear 
extrapolation. Two independent experiments were conducted to verify the IC50. For subsequent 
assays, SNO cells were treated FA at a concentration equal to its IC50. 
% Cell viability = FA treated cells (mean OD) x 100 
       Control cells (mean OD) 
 
2.5 ATP quantification assay 
2.5.1 Introduction 
ATP is a coenzyme that transports chemical energy throughout the cell and is required for 
metabolism. ATP is produced through substrate level phosphorylation in the TCA cycle, 
glycolysis and oxidative phosphorylation in the ETC during cellular respiration (Figure 2.3). 
The levels of intracellular ATP are indicative of respiratory capacity and mitochondrial function 
(Bergman, 1999). 
 
Figure 2.3: The sequential processes that lead to intracellular ATP production, namely 
glycolysis, the TCA cycle and the ETC. ATP production in the ETC is driven by electron 





Intracellular ATP levels were quantified using a CellTiter-Glo® assay (Promega, Madison, 
Wisconsin, USA). The assay uses bioluminescence to determine intracellular ATP levels. 
Bioluminescence is the generation and emission of light by an organism due to a chemical 
reaction whereby chemical energy is transformed into light energy and the outcome is 
chemiluminescence (visible light) (Hastings, 2014). The assay is based on the luciferin-
luciferase reaction that occurs in the firefly. Luciferase is the enzyme that catalyses the mono-
oxygenation of D-luciferin in the presence of magnesium, ATP and oxygen, producing inactive 
oxyluciferin (Figure 2.4). The intensity of light that is produced by this reaction is directly 
proportional to the concentration of intracellular ATP (Hastings, 2014). 
 
Figure 2.4: The luciferin-luciferase reaction. Mono-oxygenation of luciferin is catalysed by 
luciferase enzyme in the presence of magnesium ions, ATP and oxygen. This reaction gives of 
CO2 and light as by products (Prepared by Author). 
 
2.5.2 Protocol 
For the CellTitre-Glo assay, 50 µl of cell suspension (20,000 cells/well in 0.1 M PBS) was 
seeded into a white, opaque 96-well luminometer plate in triplicate. Thereafter, 20 µl of reagent 
was added into each well followed by incubation of the plate in the dark for 30 minutes (min) at 
room temperature (RT) to allow for the luciferin-luciferase reaction to occur. Luminescence, 
which is proportional to the level of intracellular ATP, was then detected using a Modulus™ 
microplate luminometer (Turner Biosystems, Sunnyvale, USA). The level of ATP was 








2.6 Glutathione assay 
2.6.1 Introduction 
Endogenous antioxidant defence systems combat excessive levels of ROS thus dampening 
ROS-associated toxicity. The most abundant endogenous antioxidant which functions in cellular 
defence and detoxification is glutathione. Glutathione exists predominantly in its biologically 
active form, reduced glutathione (GSH). In the presence of ROS, GSH acts as an electron donor 
and is oxidised to form GSSG. Oxidation of GSH results in a decreased ratio of GSH: GSSG. 
The recycling of GSH and GSSG are carried out by glutathione-S-transferase (GST) and GSH 
peroxidase (GPx) (Figure 2.5) (Circu and Aw, 2008). 
 
Figure 2.5: Reactions associated with the interconversion of the two different forms of 
glutathione. Detoxification of H2O2 by GPx requires GSH to generate water and GSSG, while 
regeneration of GSH from GSSG by GST requires NADPH as a cofactor (Prepared by Author). 
	  
The GSH luminometric assay is also based on the luciferin-luciferase reaction, where Luciferin-
NT is converted to Luciferin by GST. This reaction consumes GSH and gives off ATP and 
oxygen as by-products. Thereafter, Luciferin is converted by Luciferase to produce light which 
is detected by a luminometer (Hastings, 2014). 
 
2.6.2 Protocol 
Intracellular glutathione (GSH) levels were quantified using the GSH-Glo™ assay (Promega, 
Madison, USA). Briefly, 50 µl of cell suspension (20,000 cells/well in 0.1 M PBS) were seeded 
into a white, opaque 96-well luminometer plate in triplicate. A 5 mM stock diluted in 0.1 M 
PBS was used to make GSH standards ranging from 0-50 µM. Subsequently, 50 µl per GSH 
standard and 50 µl of 2× GSH-Glo™ Reagent were added into each well and incubated for 30 
min in the dark at RT. Thereafter, 50 µl of Reconstituted Luciferin Detection Reagent was 
added into each well and incubated for 15 min at RT. Luminescence was measured on a 









2.7. Thiobarbituric acid reactive substances (TBARS) assay  
2.7.1 Introduction 
Quantification of endogenous ROS is challenging as ROS have short half-lives. By-products of 
ROS are often used to quantify the extent of oxidative damage. Lipid peroxidation, the 
oxidation of polyunsaturated fatty acids in lipids by ROS, is a common biomarker for oxidative 
stress (Figure 2.6). The double bond and ethylene bridges in polyunsaturated fatty acids contain 
highly reactive hydrogen atoms which can readily interact with ROS (Fernández et al., 1997). 
 
Figure 2.6: Free radical chain reaction of lipid peroxidation. Initiation involves the reaction of a 
free radical with a polyunsaturated fatty acid, forming a fatty acid radical. Propagation refers to 
the reaction of oxygen with the fatty acid radical to produce a fatty acid peroxyl radical. 
Termination entails the formation of the end product of lipid peroxidation, malondialdehyde 
(MDA) (Prepared by Author). 
 
The Thiobarbituric Acid (TBA) Reactive Substances (TBARS) assay measures the 
concentration of the end product of lipid peroxidation, MDA (Asakawa and Matsushita, 1979). 
The principle of this assay is based on the ability of two molecules of TBA to condense with 
one molecule of MDA at a high temperature and low pH to form a red pigment that absorbs 
light at 532 nm. MDA reacts with the methylene group of TBA to form adducts. The colour 
intensity is proportional to the concentration of MDA which is measured using a 







Approximately 200 µl of supernatant per control/treatment was added into appropriately 
labelled, clean glass test tubes containing 200 µl of 2% phosphoric acid (H3PO4). This acidifies 
the samples so that any interfering proteins or enzymes become dysfunctional. Experimental 
assurance was accounted for by preparation of a negative control (3 mM HCl) and positive 
control (1 µl MDA). Thereafter, 200 µl of 7% H3PO4 was added to each of the tubes followed 
by 400 µl of TBA/Butylated hydroxytoluene (BHT) solution to every sample except the blank. 
BHT is an antioxidant which minimises artefact oxidation during the heating process, hence, 
BHT is used in conjunction with TBA as TBA is unspecific and can react with several other 
substances to form TBARS (Asakawa and Matsushita, 1979). 
Each tube was briefly vortexed and the pH of each sample was adjusted using 1 M HCl to pH 
1.5. The tubes were subsequently boiled in a water bath for 15 min at 100°C to allow for 
optimal hydrolysis of MDA-adducts. After the samples were allowed to cool to RT, 1500 µl of 
butanol was added to each tube in order to extract MDA by separating the solution into phases. 
The tubes were then vortexed and allowed to stand for the two phases to become distinct. A 
volume of 500 µl of the upper butanol phase was transferred to sterile 1500 µl micro-centrifuge 
tubes. This was followed by centrifugation (2500xg; 24°C; 6 min) and 100 µl of each sample 
was transferred to a 96-well microtitre plate in triplicate. The absorbance was measured at 532 
nm with a reference wavelength of 600 nm using a Bio-Tek µQuant spectrophotometer. The 
average of 3 replicates were calculated and divided by the absorption coefficient, 156 mM-1 to 
determine the average concentration of MDA (µM). MDA levels were represented as relative 
fold change. 
 
2.8 Lactate dehydrogenase cytotoxicity detection assay 
2.8.1 Introduction 
Lactate dehydrogenase (LDH) is an oxidoreductase which catalyses the interconversion of 
pyruvate and lactate during glycolysis and is localised in the cytosol. Upon cellular damage, the 
cell membrane integrity becomes compromised. Consequently, cellular contents, including 
cytosolic LDH leaks from the cytosol into the extracellular matrix (Watanabe et al., 1995). The 
LDH cytotoxicity detection kit (11644793001) (Roche, Mannheim, Germany) was used to 
quantify cell damage and this was measured using colorimetric analysis. The assay consists of 
two serial enzymatic reactions. First, nicotinamide adenine dinucleotide (NAD+) is reduced to 
NADH/H+ via conversion of lactate to pyruvate. Subsequently, an oxidase (diaphorase enzyme) 
catalyses the transfer of H/H+ from NADH/H+ to a tetrazolium salt, iodonitrotetrazolium (INT) 






Figure 2.7: Intracellular lactate dehydrogenase (LDH) is released into the extracellular matrix 
when cell membrane integrity is compromised. Extracellular LDH is detected and measured by 
means of the oxidation of lactate with attendant reduction of NAD to NADH which is then used 
to produce a coloured substrate quantifiable via colorimetric analysis. INT: iodonitrotetrazolium 
(Prepared by Author). 
 
2.8.2 Protocol 
To quantify the level of extracellular LDH, 100 µl of supernatant per sample was added into a 
96-well microtitre plate in triplicate. Thereafter, 100 µl of solution from the kit containing dye 
solution (INT/sodium lactate) and catalyst (diaphorase/NAD+) was transferred to each well. 
This was followed by incubation in the dark for 25 min at RT. Absorbance was measured at 500 
nm using a spectrophotometer (Bio-Tek µQuant). The OD values of replicates were averaged 
and LDH levels was expressed as mean OD. 
 
2.9 Assessment of caspase activity 
2.9.1 Introduction 
Caspases are cysteine-aspartate proteases that are involved in the initiation (caspase-8 and -9) 
and execution (caspase-3/7) of apoptosis (Fan et al., 2005). The luminometric assay used to 
assess caspase activity is based on the cleavage of the luciferin substrate which is specific to 
caspases. This reaction produces light which is directly proportional to caspase activity (Figure 






Figure 2.8: Reaction underlying the principle of the luminometric assay which quantifies 
caspase activity. Specific binding sequences of each caspase is cleaved by luciferin in the 
presence of ATP and O2, and is converted by the enzyme, Luciferase, in the presence of 
magnesium (Mg2+) to produce light (Prepared by Author). 
 
2.9.2 Protocol 
The activities of caspase-3/7, -8 and -9 were detected with Caspase-Glo® assay (Promega, 
Madison, USA). Briefly, 50 µl of cell suspension (20,000 cells/well in 0.1 M PBS) were seeded 
into a white, opaque 96-well microtitre plate in triplicate. As per manufacturer’s guidelines, 
Caspase-Glo®-3/7, -8 and -9 reagents were reconstituted and 20 µl was added into each well. 
Thereafter, the plate was incubated in the dark (30 min, RT). Luminescence was detected using 
a Modulus™ microplate luminometer and expressed as relative fold change. 
 
2.10 Western blotting 
2.10.1 Introduction 
Western blotting is a technique used to detect and quantify the expression of specific proteins in 
a homogenous sample. This is achieved by separating proteins through a gel, based on their 
molecular weight. Distinct proteins are transferred to a firm membrane which is probed by 
antibodies (Abs) that bind to specific proteins. Chemiluminescent detection of the protein of 
interest is achieved by developing the membrane using a substrate that binds to an enzyme 
attached to the Ab. Proteins are represented as bands and the band width is proportional to the 








Protein isolation & preparation-  
Initially, protein is isolated from cell lysates. Total protein was extracted using Cytobuster™ 
reagent (catalog no. 710093, Novagen, San Diego, CA, USA), supplemented with protease and 
phosphotase inhibitor (Roche, Germany, 05892791001 and 04906837001 respectively), as per 
manufacturer’s instructions. Cytobuster reagent (200 µl) was added to cells in a 25 cm3 flask 
and left on ice for 30 min. The cells were lysed mechanically, aspirated and centrifuged to 
isolate the crude protein extract (4°C, 10 min, 10,000xg). 
Crude protein samples were then quantified using the bicinchoninic acid (BCA) assay (Sigma, 
Germany). The colorimetric BCA assay is based on the Biuret reaction which measures the 
production of Cu+, when peptide bonds in the sample react with Cu2+ under alkaline conditions. 
The Cu+ chromophore then reacts with 2 BCA molecules to produce a purple chromophore (562 
nm, 37°C). The colour produced is a result of the interaction between BCA and Cu2+ with amino 
acid residues (tryptophan, tyrosine and cysteine) in the protein sample (Bainor et al., 2011). 
Bovine serum albumin (BSA) was used to make protein standards (0, 0.2, 0.4, 0.6, 0.8, 1 
mg/ml) to determine the concentrations of the samples. Both the standards and samples were 
incubated with a working solution (BCA and CuSO4) at 37°C for 30 min and the OD was 
measured using a µQuant Biotek ELISA plate reader (562 nm). A standard curve was generated 
using the OD values obtained for the standards to determine the concentrations of the crude 
protein samples. The samples were subsequently standardised to a concentration of 1.5 mg/ml in 
Cytobuster. Protein quantification is required to standardise samples to the same concentration 
to allow for comparison of protein expression between treated samples. 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)- 
Standardised protein samples were then boiled in Laemmli buffer [dH2O, 0.5 M Tris-HCl (pH 
6.8), 3% glycerol, 10% SDS, 12% β-mercaptoethanol, 2% bromophenol blue dye] (1:4, 20 min) 
to denature protein. Water (dH2O) was used as a solvent to homogenise the sample. Glycerol 
was used to add density to the sample to facilitate sample loading in the well and prevents 
mixing of samples. Tris-HCl was used to buffer the sample and provide negatively charged 
chloride ions to the sample. Chloride ions migrate quicker through the electric field than 
glycerol, forming an ion front moving before glycerol. The overall charge of samples was 
adjusted by the anionic detergent, SDS: this prevents side chains with positive charges from 
influencing migration toward the positive electrode. SDS surrounds proteins, forming micelles, 
giving proteins a negative charge and ensuring protein migration as a result of repulsion by SO4- 
molecules (Figure 2.9). The reducing agent, β-mercaptoethanol, was used to break disulphide 
peptide bonds to allow for distinct separation of bands based on protein size and not protein 
configuration. The tracking dye, bromophenol blue, was used to visualise protein migration 






Figure 2.9: The charge of proteins before and after application of SDS. Proteins naturally have 
positively and negatively charged R-groups; SDS is an anion which alters the charge of proteins 
to negative, regardless of its previous charge (Prepared by Author). 
 
Denatured protein samples were then separated via SDS-PAGE (Figure 2.10). Firstly, 7.5% 
resolving gel was prepared [dH2O, 1.5 M Tris, 10% SDS, Bis/acrylamide, 10% ammonium 
persulphate (APS), tetramethylene diamine (TEMED)] and allowed to polymerise (1 h). The 
decomposition catalyst, TEMED, initiates the addition of monomers to Bis/acrylamide, a cross-
linking agent, in a head-to-tail fashion. The free radical donor, APS, catalyses the 
polymerisation which creates a porous gel matrix for protein migration. Thereafter, 4% stacking 
gel was prepared (dH2O, 0.5 M Tris, 10% SDS, Bis/acrylamide, 10% APS, TEMED) and added 
on top of the resolving gel (1 h). The percentage of the resolving gel is higher (more cross-
linking) as the gel will have smaller pores to yield more distinct bands, especially for low 
molecular weight proteins. Protein samples were then subjected to an electric field (150 V, 1 h) 
using a Bio-Rad compact power supply. To facilitate the electric field by providing conducting 
ions, 1 x running (electrode) buffer (dH2O, Tris, glycine, SDS, 4°C) was used during 






Figure 2.10: The setup of the electrophoresis apparatus. Migration of proteins through a gel 




Electrophoresed protein bands were then electro-transferred from the gel to a nitrocellulose 
membrane. Electrotransfer involves equilibrating the membranes, fibre pads and gels in transfer 
buffer (dH2O, Tris, glycine, methanol, pH 8.3, 4°C) for 10 min. This is followed by 
sandwiching the gel against the membrane enclosed in fibre pads and sponges and immersion in 
transfer buffer subject to a current (400 mA, 1 h) (Figure 2.11) (Yang and Ma, 2009).  
  
Figure 2.11: Preparation of protein transfer. Assembly of sandwich comprising of the gel and 
membrane covered in sponges and fibre pads to allow for transfer of proteins from gel to 






Upon completion of protein transfer to a membrane, the target protein was immunoprobed using 
specific Abs (Figure 2.12). Prior to immune-probing, it was necessary to block the membranes 
where the protein did not bind to prevent non-specific binding of antibodies. The membrane was 
submerged in 5% BSA in Tris-buffered saline [dH2O, Tris-HCl (pH 7.4), NaCl] containing 
0.5% Tween20 (TTBS) for 1 h (RT). Thereafter, the membranes were incubated with primary 
(1°) Abs [Bax (610982), Bcl-2 (2827), Smac/DIABLO (110291), Cleaved PARP-1 (9541); 
1:1,000] for 1 h at RT and then at 4°C overnight, to allow for binding of the antibody to its 
specific target protein. The membranes were then equilibrated to RT and subsequently washed 
for ~1 h (5 washes, 10-15min each) with TTBS to wash off excess Abs that did not bind to 
target proteins (Yang and Ma, 2009).  
This was followed by immunodetection probing with a secondary (2°) Ab to the 1° Ab. The 2° 
Ab is conjugated to an enzyme, which is usually horse radish peroxidase (HRP) or alkaline 
phosphatase, to allow for detection of the protein which the Ab has bound to. The membranes 
were exposed to HRP-conjugated 2° Ab [goat anti-rabbit (7076S) Bax, Bcl-2, Smac/DIABLO 
(1:5,000), cleaved-PARP-1 (1:10,000)] for 1 h on the shaker, at RT. The membranes were 
washed again for ~1 h (5 washes, 10-15min each) with TTBS. The next part of 
immunodetection involved developing the membrane by adding a substrate that HRP recognises 
(Yang and Ma, 2009). The Clarity Western Enhanced Chemiluminescence (ECL) Substrate 
(catalog no. 1705061, Bio-Rad) was used to detect the reaction (Figure 2.13), in the Alliance 2.7 
Image Documentation System (UViTech). Protein expression was analysed using UviBand 
Advanced Image Analysis software v12.14 (UViTech). 
 
   
Figure 2.12: Principle of immunoprobing and immunodetection. Unoccupied sites on the 
membrane are blocked followed by 1° Ab binding to a specific target protein. An enzyme-
conjugated 2° Ab then binds to the 1° Ab. The enzyme is developed by a substrate to allow for 







Figure 2.13: Reactions defining immunodetection using the ECL substrate. HRP catalyses the 
conversion of H2O2 to form water and O2●. Luminol is oxidised by O2● to form aminophthalic 
acid, which reacts with enhancer molecules to produce detectable light (Prepared by Author). 
 
The membranes were washed using TTBS (3 washes, 10 min each), quenched using 5 ml H2O2 
(30 min, 37°C) and washed again (3 washes, 10 min each) before blocking in 5% BSA (1 h). 
Thereafter, the membranes were re-probed with a housekeeping protein, HRP-conjugated-anti-
β-actin [(A3854, 1:5,000) Sigma, St Louis, Missouri, USA] for 1 h at RT to normalise protein 
expression and control for loading error (Liu et al., 2014). Data was expressed as mean relative 
band density (RBD) and fold change, relative to the control and housekeeping protein. 
 
2.11 Comet assay 
2.11.1 Introduction 
The Comet, or single cell gel electrophoresis (SCGE), assay is used to detect DNA 
fragmentation in individual cells. DNA fragmentation is a late characteristic of apoptosis, a 
result of the chain reaction that occurs due to the caspase cascade. Healthy, undamaged DNA 
maintains a highly organised, supercoiled structure within the nucleus whilst damaged DNA 
loses its structural organisation and migrates out of the nucleus when subjected to an electric 
field. This principle forms the basis of the Comet assay (Figure 2.14). When an electric field is 
applied to cells embedded in agarose gel, DNA migration out of the nucleus forms a ‘comet’, 
where the head contains intact, undamaged DNA and the tail contains damaged, fragmented 
DNA. The Comet assay utilises fluorescence to visualise the presence and extent of DNA 






Figure 2.14: Principle of the Comet assay. Electrophoresis of intact DNA results in uncoiling of 
DNA, whilst that of fragmented DNA results in migration of damaged DNA out of the nuclear 
cavity forming a comet (Prepared by Author). 
 
2.11.2 Protocol 
Cells were encapsulated in low melting point agarose (LMPA). Briefly, three microscope slides 
with frosted ends per control and treatment were prepared: the first layer contained 1% LMPA 
(400 µl, 37°C) which was incubated for 10 min at 4°C; the second layer contained cell 
suspension (20,000 cells in 25 µl 0.1 M PBS), GelRedTM nucleic acid gel stain (1µl) (Biotium, 
California, cat. no. 41003) and 0.5% LMPA (175 µl, 37°C) which solidified in 10 min at 4°C; 
the third layer contained 0.5% LMPA (200 µl, 37°C) which was incubated for 10 min at 4°C. 
The layered gels were covered with coverslips (Singh et al., 1988). 
The subsequent step involved lysing the cell membranes to allow for permeation of fragmented 
DNA out of the cell. Coverslips were removed and solidified gels were submerged in cold cell 
lysis buffer [100 mM EDTA, 2.5 M NaCl, 1% Triton X-100, 10% DMSO, and 10 mM Tris (pH 
10)] and incubated (1 h, 4°C, dark). Thereafter, the slides were submerged in electrophoresis 
buffer [1 mM Na2EDTA (pH 13) and 300 mM NaOH] for 20 min at RT to allow for 
equilibration prior to electrophoresis (300 mA, 25 V, 35 min, RT) using a Bio-Rad compact 
power supply (Singh et al., 1988). 
The slides were rinsed three times (5 min each) (0.4 M Tris, pH 7.4) to neutralise the samples 
prior to replacement of coverslips. The slides were then viewed using a fluorescent microscope 
(Olympus IX51 inverted microscope, excitation: 510-560 nm; emission 590 nm). Images of 50 
cells and comets were captured in total from three slides per control/treatment. Lengths of cells 
and comet tails were measured using Soft imaging system (Life Science - ©Olympus Soft 





2.12 Hoechst Assay 
2.12.1 Introduction 
Hoechst 33342 is a water soluble and cell permeable dye that fluoresces blue (Figure 2.15). The 
dye binds to minor grooves of double stranded (ds) nucleic acids, specifically the adenine-
thymine (AT)-rich regions. Hoechst likewise binds to guanine-cytosine (GC)-rich regions on 
DNA, but fluorescence is enhanced by two-fold when bound to AT-rich regions of dsDNA. 
Binding affinity of the dye is also higher to AT-rich regions rather than GC-rich regions. 
Hoechst fluorescence (excitation- 350 nm, emission- 461 nm) is sensitive to the conformation of 
DNA and chromatin structures; hence it can detect the extent of damaged nuclear components. 
In a cell undergoing apoptosis, the Hoechst dye is used to visualise apoptotic bodies, 
fragmented DNA and hypercondensed chromatin (Vekshin, 2011). 
 
Figure 2.15: Hoechst 33342 staining of nucleus. Hoechst dye permeates the cell membrane and 
enters the nucleus where it binds to dsDNA and fluoresces blue (Prepared by Author). 
 
2.12.2 Protocol 
Nuclear structure and cellular morphology was assessed in SNO cells treated with FA by 
staining with Hoechst 33342 (H3570) (Invitrogen™, Eugene, Oregon, USA). Cells were seeded 
(500,000 cells) into a 6-well plate and treated in triplicate for 24 h. Cells were thereafter washed 
three times (0.1 M PBS) and fixed in 10% paraformaldehyde (PFA) (5 min) to preserve the 
cells. The cells were washed again (0.1 M PBS) to remove excess PFA. Hoechst working 
solution (5 µg/ml in 0.1 M PBS) was added and incubated (15 min, 37°C). Prior to viewing, 
cells were washed to remove any dye that did not bind to nucleic acids in the sample. Images 
were captured using a fluorescent microscope (excitation- 350 nm, emission- 450 nm). Ten 





2.15 Statistical analysis  
Statistical analyses were carried out using GraphPad Prism v5.0 software (GraphPad Software 
Inc., La Jolla, USA). The concentration-response-inhibition equation produced an IC50 for MTT 
assay. The statistical significances were determined by unpaired t-test with Welch’s correction 
(results reported as mean ± standard deviation (SD)) and a 95% confidence interval with a p 








3.1 Metabolic activity & cell viability 
3.1.1 Methylthiazol tetrazolium (MTT) assay 
The MTT assay was used to measure FA toxicity in SNO cells over 24 h. Serial dilutions of FA 
(0-500 µg/ml) was used to determine a dose response (Addendum A). Analysis of the dose 
response curve revealed that a concentration of 78.81 µg/ml was sufficient to cause 50% of 
SNO toxicity (IC50) and this concentration of FA was used in all subsequent assays (Figure 3.1). 
 
Figure 3.1: FA induced a dose-dependent decrease in SNO cell viability following treatment 
for 24 h. Data represented as a percentage of viable cells relative to the untreated control. 
Higher concentrations showed increased cell death rates.  
 
3.1.2 ATP quantification 
The concentration of ATP in SNO cells was assessed via luminometry. The ATP levels were 
significantly reduced by FA with a 1.16-fold decrease (3,628,000 ± 79,920 RLU) compared to 
the control (4,212,000 ± 120,900 RLU; p = 0.006) (Figure 3.2). 
 
Figure 3.2: Levels of ATP in control vs FA treated SNO cells. FA significantly decreased ATP 






3.2 Oxidative stress 
3.2.1 Lipid peroxidation 
Lipid peroxidation induced by ROS was measured by quantifying the extracellular MDA, i.e. 
the end product of lipid peroxidation, as an indicator of oxidative stress. FA increased levels of 
extracellular MDA by a significant 1.23-fold (1.242 ± 0.03 µM) compared to that of control 
cells (1.007 ± 0.003 µM, p = 0.0166) (Figure 3.3). 
 
Figure 3.3: FA increased levels of extracellular MDA. MDA: malondialdehyde. *p < 0.05 
relative to control. 
 
3.2.2 Antioxidant response 
Reduced glutathione (GSH) levels were measured as an indicator of endogenous antioxidant 
capacity. Lipid peroxidation was concomitant with decreased levels of intracellular GSH (1.62-
fold) in FA treated SNO cells (0.617 ± 0.006 µM) compared to that of the control (1.01 ± 0.006 
µM, p < 0.0001) (Figure 3.4). 
 
Figure 3.4: FA significantly reduced levels of intracellular GSH (p < 0.0001). GSH: reduced 






3.3 Reduced membrane integrity 
3.3.1 Increased extracellular LDH 
Extracellular LDH levels were quantified using the LDH cytotoxicity detection kit. FA induced 
significant SNO cell membrane damage when compared to control SNO cells as measured by 
increased extracellular LDH levels (control: 1.849 ± 0.018 OD; FA: 2.122 ± 0.004 OD, p = 
0.002) (Figure 3.5). 
 
 
Figure 3.5: FA significantly increased LDH leakage in SNO cells indicative of membrane 
damage. FA is cytotoxic to SNO cells. LDH: lactate dehydrogenase, OD; optical density. **p < 
0.005 relative to control. 
 
3.4 Apoptotic induction 
3.4.1 Protein expression of Bax, Bcl-2, Smac/DIABLO and cleaved-PARP-1 
Expression of pro- and anti-apoptotic proteins were measured via Western blotting. FA induced 
a significant 1.08-fold increase in Bax expression (0.0726 ± 0.0008 RBD vs. control: 0.0675 ± 
0.0005 RBD, p = 0.0138) [Figure 3.6 (A)]; a 1.02-fold increase in Smac/DIABLO expression 
(1.026 ± 0.0287 RBD vs. control: 1.003 ± 0.003 RBD) [Figure 3.6 (C)]; a significant 1.24-fold 
decrease in Bcl-2 expression (0.8131 ± 0.0176 RBD vs. control: 1.010 ± 0.0058 RBD, p = 
0.0087) [Figure 3.6 (B)], and a significant 1.53-fold increase in the 24 kDa fragment of PARP-1 
(2.02 ± 0.077 RBD vs. control: 1.325 ± 0.1117 RBD, p = 0.0143), indicating DNA damage 






Figure 3.6: FA regulates protein expression of A. Bax (p < 0.05), B. Bcl-2 (p < 0.05), C. 
Smac/DIABLO and D. cleaved PARP-1 (p < 0.05) in SNO cells after treatment for 24 h. Pro-
apoptotic protein expression was upregulated (Bax) with the same protein expression of 
Smac/DIABLO in treated and untreated cells, while anti-apoptotic protein expression was 
reduced (Bcl-2), indicating apoptotic induction. Increased expression of the 24 kDa fragment of 
PARP-1 showed that DNA strand breaks were not repaired by the PARP-1 enzyme resulting in 
DNA fragmentation. *p < 0.05 relative to the control. 
 
3.5 Caspase activation 
3.5.1 Initiator and executioner caspase activation 
The activity of caspase-3/7, -8 and -9 were assessed via luminometry. FA significantly 
increased the activity of all caspases measured: caspase-3/7 by 1.17-fold (p = 0.0306) [Figure 
3.7 (C)]; caspase-8 by 1.34-fold (p = 0.013) [Figure 3.7 (A)] and caspase-9 by 1.24-fold (p = 
0.0059) in SNO cells [Figure 3.7 (B)]. FA induced caspase-dependent apoptosis in SNO cells 






Figure 3.7: FA significantly influenced caspase activity. Activity of A. initiator caspase-8 and 
B. caspase-9, as well as C. executioner caspase-3/7 were significantly elevated in FA treated 
SNO cells (p < 0.05) compared to the control. *p < 0.05 relative to the control. 
 
3.6 Late stages of apoptosis 
Late stages of apoptosis are characterised by hypercondensed nuclei, apoptotic body formation 
and DNA fragmentation. Hoechst staining showed higher cell density and healthy cells 
undergoing various stages of mitosis in the untreated control [Figure 3.8 (A)], while FA induced 
nuclear condensation, apoptotic body formation and DNA fragmentation in SNO cells after 24 h 






Figure 3.8: Nuclear morphology of untreated SNO cells vs FA treated SNO cells. A. Uptake of 
Hoechst 33324 stain by untreated SNO cells showing (a) early prophase, (b) metaphase, (c) late 
anaphase, (d) early telophase and (e) late telophase. B. FA induced (a) apoptotic body 
formation, (b) chromatin condensation, (c) DNA fragmentation and reduced SNO cell density as 
compared to control (20x). 
 
3.7 Damage of nuclear components 
3.7.1 DNA damage 
The comet assay was used to detect fragmented DNA in SNO cells, where longer comet tails 
indicate a greater extent of DNA fragmentation. Figure 3.9 (B) shows significantly longer comet 
tails in FA treated cells (5.926 ± 0.0795 µm) compared to control cells (3.092 ± 0.2102 µm, p < 






Figure 3.9: DNA damage induced by FA. DNA fragmentation was increased in B. FA treated 
cells with longer comet tails (***) compared to A. control cells with larger comet heads 







FA, a mycotoxin produced by the ubiquitous soil fungus, Fusarium heterosporum, is a major 
contaminant of maize and maize products (Bacon et al., 1996). Consumption of mycotoxin-
contaminated maize as a staple may contribute to the high incidence of OC worldwide, and 
especially among black South African men. FA is known to have low to moderately toxic 
effects in plants and has been suggested as a causative agent of OC (Nedělník, 2002), however 
the effects of FA in humans has not yet been conclusively explored. It was hypothesised that FA 
induces cytotoxic effects on SNO cancer cells upon acute exposure. 
The mitochondrion is a major metabolic cellular organelle performing several key functions 
including aerobic respiration which is responsible for generating cellular energy. The MTT 
assay measures metabolic activity of the mt respiratory chain by quantifying the ratio of 
reducing equivalents to oxidising equivalents in the cell (Mosmann, 1983). FA revealed a dose-
dependent decrease in cellular metabolic activity and viability in SNO cells as observed by the 
MTT assay (Figure 3.1). Reduced metabolic activity may be due to a decrease in the rate of the 
Kreb’s cycle that leads to a decreased output of reducing equivalents and ATP (Telles-Pupulin 
et al., 1998). These reducing equivalents are required by the mt respiratory chain within the mt 
membrane, as well as for MTT salt reduction to generate a formazan product (Mossmann, 
1983).  
The disruption of the mt respiratory chain leads to a disruption of the mt membrane proton 
gradient, which is essential for functioning of ATPase to generate ATP. The butyl tail of FA 
impairs the activity of cytochrome c oxidase, resulting in slow movement of electrons and 
uncoupling of the respiratory chain from ATP synthesis (Gäumann, 1958). FA also decreases 
the activity of succinate dehydrogenase and α-ketoglutarate dehydrogenase in the Kreb’s cycle, 
further contributing to dissipation of the proton gradient (Telles-Pupulin et al., 1998). Thus, the 
alteration in the cellular NADH/NADPH reductase system corresponds with the significant 
decrease in ATP by FA in SNO cells (Figure 3.2). Recent work by Sheik Abdul et al. proposed 
that FA induced oxidative and mitochondrial stress in the hepatocellular carcinoma HepG2 cell 
line (Sheik Abdul et al., 2016). 
Mitochondria are also major ROS producing organelles and are prone to oxidative damage. 
Limited electron transfer as a result of mt membrane disruption leads to excessive production of 
ROS. Increased ROS, coupled with a decrease in the endogenous antioxidant GSH leads to 
oxidative stress, accompanied by the oxidation of DNA and lipids (Circu and Aw, 2010). FA 
significantly increased the level of ROS-induced lipid peroxidation (Figure 3.3) and 
simultaneously decreased levels of GSH, compared to control cells (Figure 3.4). FA thereby 
disrupts the mt membrane of SNO cells and processes that occur within it, leading to oxidative 
stress. 
Lipid peroxidation disrupts cellular membrane integrity. Membrane disintegration may be 
accentuated by damage caused by the lipid-soluble butyl tail of FA as it penetrates through the 
cell membrane (Dowhan, 1997, Fernández-Pol, 1998). FA also has the ability to chelate divalent 
cations between the N atom of the pyridine ring and the carboxyl radical (Gäumann, 1958). 
Divalent cations, particularly Ca2+ and Zn2+, interact with membranous phospholipids to allow 
for the essential process of signal transduction (Träuble and Eibl, 1974). Furthermore, these 





membrane permeability subsequent to breach by toxins. Therefore, this chelating effect 
contributes to cell membrane damage (Bashford et al., 1986).  
To assess the integrity of the cell membrane, extracellular levels of LDH were measured, since 
LDH is exclusively found in the cytoplasm and only exits the cell through damaged membranes 
(Watanabe et al., 1995). The significant increase in extracellular LDH levels (Figure 3.5) 
confirmed that FA disrupts the cellular membrane of SNO cells. Thus both the mt membrane 
and cell membrane of SNO cells are affected by FA. 
Since FA affected the mt membrane, the expression of mt proteins were analysed. The Bcl-2 
family of proteins, particularly Bax and Bcl-2 are important in apoptosis, as MPTPs in the mt 
membrane consist of and are regulated by Bax and Bcl-2. Bax, a pro-apoptotic protein which is 
inhibited by Zn2+, induces the formation of MPTPs by interacting with lipids in the OMM 
(Ganju and Eastman, 2003). FA significantly increased Bax protein expression [Figure 3.6 (A)]. 
This suggests a role of FA in Zn2+ chelation, as this would allow for Bax activation. Bcl-2 is an 
anti-apoptotic protein and inhibitor of Bax (Hockenbery et al., 1990). FA caused a significant 
decrease in Bcl-2 expression [Figure 3.6 (B)], thus preventing its inhibitory effect on Bax 
activation. 
Upon formation of MPTPs, mt pro-apoptotic proteins such as Cyt c and Smac/DIABLO are 
released into the cytoplasm. Cyt c binds to Apaf-1, which recruits pro-caspase-9 to form an 
ATP-requiring apoptosome. This apoptosome cleaves pro-caspase-9 to form active caspase-9, 
the initiator caspase of the intrinsic pathway. Caspase-9 activates executioner caspase-3/7, 
which mediates proteolysis of apoptotic cells. Caspase-8, the initiator caspase of the extrinsic 
pathway, activates Bid which activates Bax. The pro-apoptotic protein, Smac/DIABLO, 
functions to inhibit the activity of IAPs, which inhibit caspase-3/7 and -9 (Ashkenazi and Dixit, 
1998, Green and Reed, 1998, Guicciardi and Gores, 2005). Levels of Smac/DIABLO were the 
same in control and FA-treated cells [Figure 3.6 (C)]. FA significantly increased the activation 
of caspases -3/7, -8 and -9 (Figure 3.7) in SNO cells, compared to control cells. 
Active caspase-3/7 cleaves the 75 kDa subunit of complex I of the ETC disrupting electron 
transport and mt membrane permeability (Ricci et al., 2004), further increasing ROS 
production, ATP depletion and mt damage. 
PARP-1, an ATP-dependent Zn-finger endonuclease, is activated by caspase-3/7 and binds to 
breaks of internucleosomal DNA. PARP-1 is a 113 kDa protein, which when cleaved, forms an 
89 kDa and a 24 kDa fragment. PARP-1 also contains a Zn-finger domain which can be 
chelated by FA, which causes PARP-1 cleavage and renders PARP-1 ineffective in its DNA 
binding and repair activity (Kaufmann et al., 1993). Zn inhibits PARP-1 cleavage and is 
therefore essential to allow for the binding of PARP-1 to DNA strand breaks. This is achieved 
by Zn inhibition of the catalytic function of caspase-3/7 by interaction with either or both of the 
conserved sites, Cys-285 and His-237. This is another mechanism by which Zn chelation would 
allow for PARP-1 cleavage to occur (Perry et al., 1997). A significant increase in the expression 
of the 24 kDa fragment of PARP-1 indicates that PARP-1 is cleaved by FA and contributes to 
DNA damage [Figure 3.6 (D)]. This result may be due to the chelating effect of FA on Zn and 
hence the significant increase in caspase-3/7 activity.  
DNA damage was assessed which showed FA treated cells had fragmented DNA as longer tails 
[Figure 3.9 (B)] compared to intact DNA in the control cells [Figure 3.9 (A)]. Other late stages 
of apoptosis include condensation and damage of nuclear components followed by formation of 





hypercondensation of nuclei, DNA fragmentation and resulted in the formation of a substantial 




Figure 4: Schematic overview of the biochemical effects of FA on membrane integrity, 







4.2 Conclusion and Recommendations 
FA is a major contaminant of maize and has been suggested as an aetiological agent of OC. 
However, the mechanism by which FA causes cytotoxicity in oesophageal cells has not been 
elucidated. In this study, the cytotoxic effects in the SNO cell line were determined (Figure 4).  
Results showed that FA induced oxidative stress by increasing the level of ROS-induced lipid 
peroxidation and concomitantly reducing antioxidant response, which simultaneously resulted 
in membrane damage. Disruption of mt activity was associated with decreased output of 
reducing equivalents and low ATP levels. Collectively, these events triggered the recruitment of 
apoptotic machinery which compromised DNA integrity and averted its repair, leading to cell 
death via both intrinsic and extrinsic apoptosis. Taken together, FA is a cytotoxic agent to 
human oesophageal SNO cells. Understanding the mechanism of toxicity of FA in humans may 
aid in preventing and treating the outcomes of consuming FA-contaminated agricultural 
produce. 
Chelation by FA was not tested in this study as the assay was not entirely optimised for the 
SNO cell line. Based on present findings, further studies are required to determine if the 
chelating effects of FA are associated with the outcomes of this study, particularly the effect of 
Zn chelation on Zn-finger proteins such as PARP-1, p53, SOD and IAP. The consistency of FA 
in other cell lines (including normal oesophageal cells) must be established as this study serves 
as a preliminary study. Further studies on the effects of FA are needed using an in vivo 
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Cell Viability Raw Data 
SNO cells were treated with a range of FA concentrations (0 – 500 µg/ml) over a 24 h period. 
The MTT assay revealed a dose-dependent decrease in SNO cell viability and an IC50 of 78.81 
µg/ml was determined (Appendix Table 1). 
Table 1: SNO cell viability treated with a range of FA concentrations (0 – 500 µg/ml) for 24 h. 
FA concentration (µg/ml) Log [FA] Mean Absorbance ± SD % Viability 
0 0 0.605 ± 0.056 100 
25 1.398 0.471 ± 0.013 77.796 
50 1.699 0.402 ± 0.041 66.501 
100 2 0.268 ± 0.011 44.353 
250 2.398 0.129 ± 0.053 21.322 
350 2.544 0.040 ± 0.004 6.612 
500 2.699 0.024 ± 0.002 4.022 







Table 1: Formulation of Eagle’s Minimum Essential Medium 
Component  Concentration (µg/L) 
Amino acids L-arginine-HCl 126 
 L-Cystine • 2HCl 31.3 
 L-Histidine-HCl • H2O 42 
 L-Isoleucine 52 
 L-Leucine 52 
 L-Lysine • HCl 72.5 
 L-Methionine 15 
 L-Phenylalanine 32 
 L-Threonine 48 
 L-Tryptophan 10 
 L-Tyrosine • 2Na • 2H2O 51.9 
 L-Valine 46 
Inorganic salts CaCl2 • 2H2O 200 
 KCl 400 
 MgSO4 (anhydrous) 97.7 
 NaCl 6800 
 NaH2PO4 (anhydrous) 122 
Vitamins Choline chloride 1 
 D-Pantothenate • ½Ca 1 
 Folic acid 1 
 myo-Inositol 2 
 Niacinamide 1 
 Pyridoxal • HCl 1 
 Riboflavin 0.1 
 Thiamine • HCl 1 
Other Glucose 1000 








Raw data- Caspase Activity, ATP levels, LDH levels 
Table 1: Caspase activity, ATP levels and LDH levels in SNO cells following FA treatment. 
  Absorbance (RLU) Mean 
RLU 
Relative fold 
change ± SD   A B C 
Caspase-8 
Control 316787 257096 254571 276151 
1.34 ± 0.064 
FA 325192 346962 439446 324863 
Caspase-9 
Control 284530 340268 285561 303453 
1.24 ± 0.029 
FA 360877 356767 411209 353555 
Caspase-
3/7 
Control 7016.4 6738.2 7474.7 7440.7 
1.17 ± 0.048 
FA 7802.9 8077.1 8889.8 8256.6 
  Absorbance (RLU) 
Mean RLU ± SD 
  A B C 
ATP 
Control 4351040 4128210 4158210 4212487 ±120924 
FA 3716890 3605480 3561930 3628100 ± 79918 
  Absorbance (OD) 
Mean OD ± SD 
  A B C 
LDH 
Control 1.861 1.858 1.829 1.849 ± 0.018 
FA 2.119 2.124 1.966 2.122 ± 0.004 








Protein quantification and standardisation using bovine serum albumin (BSA) 
Table1: Absorbance values of serially diluted concentrations of BSA used as standards. 
BSA standards (mg/ml) OD1 OD2 OD3 Mean OD SD 
0 0.095 0.09 0.09 0.092 0.003 
0.2 0.445 0.427 0.429 0.434 0.01 
0.4 0.607 0.62 0.616 0.614 0.007 
0.6 0.854 0.806 0.767 0.809 0.044 
0.8 1.079 0.928 0.954 0.987 0.081 
1 1.127 1.077 1.193 1.132 0.058 




Figure 1: Standard curve using known concentrations of BSA. Equation of the line was used to 
determine the concentration of control and treatment protein samples via the BCA assay. BSA: 
Bovine serum albumin, OD: Optical density. 
 
y = 1.0083x + 0.1739 





















Table 2: Standardisation of protein samples (control & FA) to 1.5 mg/ml using standard curve 
of BSA concentrations. 
Sample Mean OD Protein (mg/ml) C2 (mg/ml) V2 (µl) V1 (µl) 
Control 2.317 2.125 1.5 200 141.18 
FA 1.671 1.586 1.5 200 189.16 






Glutathione (GSH) Assay- Raw data 
Table 1: Absorbance values (RLU) of serially diluted GSH used as standards. 
 Absorbance (RLU)  
GSH standards (µM) A B C Mean RLU 
0 52707 54025.7 67614.7 58115.8 
3.125 768442 778701 631743 726295.3 
6.25 1225850 1154050 767117 1189950 
12.5 1455670 1608900 197537 1532285 
25 1698740 2029640 340.006 1864190 
50 2688090 2658140 406.008 2673115 
GSH: reduced glutathione, RLU (Relative light units). 
 
 
Table 2: Absorbance values of samples (RLU) 
 Absorbance (RLU)  
Sample A B C Mean RLU 
Control 1016610 989729 1031060 1012466 
FA 875122 848530 858431 860694.3 







Figure 1: Standard curve representing mean absorbance values of GSH concentrations. RLU: 
Relative light units. 
  
y = 44874x + 616136 






















Comet Assay- Raw data 
Table 1: Comet tail lengths of control and FA treated SNO cells 
 Control (µm) FA (µm) 
1 2.71 6.32 
2 2.06 6.71 
3 1.55 6.19 
4 1.16 5.29 
5 1.03 6.06 
6 1.29 6.58 
7 1.42 5.93 
8 1.68 6.42 
9 1.55 6.8 
10 1.29 6.58 
11 1.81 6.06 
12 1.55 5.68 
13 1.81 5.03 
14 1.68 5.03 
15 1.29 6.19 
16 1.16 5.8 
17 1.03 5.03 
18 1.16 5.93 
19 1.42 5.93 
20 0.90 6.19 
21 1.55 5.93 
22 4.84 5.93 
23 4.84 6.06 
24 4.19 5.16 
25 4.84 7.09 
26 4.51 6.32 
27 4.19 6.06 
28 4.84 6.71 
29 3.55 5.29 
30 4.84 5.8 
31 4.84 5.42 
32 3.55 5.93 
33 4.19 6.06 
34 4.51 4.9 
35 4.51 6.06 
36 4.51 5.42 
37 3.55 5.03 
38 4.84 6.32 
39 4.19 7.22 
40 4.19 6.32 





42 3.22 5.03 
43 2.9 6.06 
44 4.19 6.29 
45 4.19 5.65 
46 4.84 5.29 
47 4.84 6.09 
48 4.84 5.93 
49 4.19 5.29 
50 4.19 5.58 










Figure 1: FA induced a significant decrease in protein expression of p53 (p = 0.0334). 
 
The tumour suppressor protein, p53 contains Zn-finger domains. FA is a chelator of divalent 
metal cations, including Zn. FA induced a significant 1.09-fold decrease in p53 protein 
expression. Normally, upregulation of p53 signals for cell cycle arrest and DNA repair. 
However, the damage to DNA caused by FA was not repaired due to reduced expression of p53, 
thus the excessive amount of DNA damage observed. The Zn-chelation property of FA may 
have explained the reduced expression of p53, however, chelation was not tested in this study.  
This result indicates that FA induced p53-independent apoptosis in SNO cells after 24 h of 
treatment. 
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a b s t r a c t 
 
Oesophageal cancer (OC) is a global problem incrementally incident among black South African males. The high incidence of 
OC may be due to the consumption of corn as a staple, often contaminated with mycotoxins. Fusaric acid (FA), a neglected 
mycotoxin, is known to disrupt mitochondrial energy meta-bolism, chelates divalent metal cations and induces cell death in 
plants. This study investigated FA-induced cytotoxicity and apoptotic induction in the SNO OC cell line. Cells were treated 
with FA (IC50 ¼ 78.81 mg/mL; 24 h; MTT assay) and assayed for oxidative stress and membrane damage (TBARS, LDH 
cytotoxicity and glutathione), apoptotic induction (ATP levels, caspase-8, -9, -3/7 activities) (Luminometry), single strand 
DNA and nuclear fragmentation (Comet and Hoechst assay). Additionally, relative expression of pro- and anti-apoptotic 
proteins were determined (Western Blotting). Significant antioxidant depletion was consistent with a concomitant increase in 
ROS-induced lipid peroxidation and extracellular LDH levels. FA induced apoptosis by significantly increasing Bax 
expression and caspase-8, -9 and -3/7 activities whilst decreasing ATP levels and Bcl-2 expression. Further, FA significantly 
increased comet tail lengths, PARP-1 expression and late stage apoptotic body formation in SNO cells. This study shows that 
FA is cytotoxic and induces increased apoptosis in SNO cells. 
 








Cancer is a major public health issue worldwide (Siegel et al., 2016). 
Oesophageal cancer (OC) is the sixth most common cause of cancer-related 
deaths worldwide and the second most common cancer among black South 
African men. The incremental incidence of OC is especially due to an 
increase in cancer-causing behaviours, particularly excessive smoking and 
alcohol consumption (Ballo and Millikan, 2015). This high OC incidence can 
also be attributed to the staple diet of corn (often heavily contaminated with 
fungi and mycotoxins) consumed by the majority South African black popu-
lation (Nedelník, 2002). Not only is corn consumed directly, but heavily 
contaminated corn is fermented to produce home brewed alcohol which 
contains a potent cocktail of mycotoxins (Cousin et al., 2005) and may 
contribute to the high incidence of OC in black South African men who 
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brewed alcohol.  
Since the oesophagus is the second organ in the digestive tract, the 
oesophagus becomes highly susceptible to exposure to contaminated food 
which may be carcinogenic. The human oeso-phageal epithelial carcinoma 
(SNO) cell line which was initially derived from a well-differentiated 
squamous cell carcinoma explanted from a 62-year old African male in July 
1972, is suitable as a transfection host and a good model for in vitro 
oesophageal toxicity testing (Bey et al., 1976). 
 
Mycotoxins, low molecular mass metabolites of fungi, that have the ability to 
damage cell membranes. The membrane-active properties of mycotoxins 
determine their toxicity, as these prop-erties enhance their mycological 
pathogenicity and self-defences. Mycotoxin contamination of corn is a global 
problem (Surai et al., 2008). Fusaric acid (FA, 5-butylpicolinic acid), a 
mycotoxin pro-duced by Fusarium heterosporum (Yabuta et al., 1937), is 
reported to have a mean volume of 643 mg/kg in feed samples (Streit et al., 
2013). 
 
FA induces several biological effects in animal and humans; FA inhibits 
tyrosine hydroxylase and dopamine b-hydroxylase, which result in elevated 
levels of serum melatonin, tyrosine, dopamine and 5-hydroxytrypamine; FA 
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which causes peripheral vascular resistance and consequential 
antihypertensive effects (Voss et al., 1999).  
FA, a metabolite of tryptophan and picolinic acid, contains a pyridine ring 
(Stack et al., 2004) that allows for the chelation of divalent metal cations 
(Gaumann,€ 1958). Chelation of divalent metal cations from catalytic DNA-
associated metalloproteins pre-vents DNA repair and synthesis, resulting in 
DNA damage (Stack et al., 2004). FA contains an n-butyl aliphatic side chain 
in the b-position which accentuates its lipophilic properties to freely penetrate 
into the cell membrane and cause damage (Fernandez-Pol, 1998). FA being a 
weak acid, will affect mitochondrial (mt) polarity and inhibit oxidative 
phosphorylation (Bachmann, 1956). 
 
Membrane disruption and the inhibition of oxidative phos-phorylation by FA 
(Telles-Pupulin et al., 1998) will contribute to a highly oxidative 
environment. Oxidative stress is defined as ‘an imbalance between oxidants 
and antioxidants in favour of the ox-idants, leading to a disruption of redox 
signalling and control and/ or molecular damage’ (Sies, 1985). Highly volatile 
reactive oxygen species (ROS) are natural by-products of cellular processes, 
including mt respiration and are necessary for normal physiological functions 
such as apoptosis, cell signalling and immunity. However, oxidation of 
nucleic acids, proteins and carbohydrates by excessive ROS causes structural 
and functional alterations in cells such as lipid peroxidation, protein carbonyl 
formation, DNA mutations/le-sions (Jezek and Hlavata, 2005). ROS are 
neutralized through endogenous antioxidants (Gutteridge, 1995). 
 
 
Chronic high ROS to antioxidant ratio can lead to deleterious effects in the 
cell and eventual cell death (Circu and Aw, 2010). Apoptosis involves an 
intrinsically regulated mechanism for death essential for the maintenance of 
tissue homeostasis, immune function, growth and development. It allows for 
the rapid removal of redundant, senescent, damaged or genetically mutated 
cells (Kerr et al., 1972). Apoptosis can occur via the extrinsic or intrinsic 
pathway, the endpoint of which is the activation of caspases to degrade 
specific cellular proteins and other constituents. Caspases regulate both the 
intrinsic and extrinsic pathways of apoptosis by proteolysis of cellular 
proteins (Fan et al., 2005). 
 







SNO cells were purchased from Highveld Biologicals (Johan-nesburg, South 
Africa (SA)). Cell culture reagents were purchased from Whitehead Scientific 
(Johannesburg, SA). Western blot re-agents were obtained from Bio-Rad 
(Hercules, CA, USA) and all antibodies from Cell Signalling Technology. All 
other reagents were obtained from Merck (Darmstadt, Germany). FA 
(Gibberella fuji-kuroi) (F6513) was obtained from Sigma Aldrich. 
 
2.2. Cell culture and FA treatment 
 
The SNO cells were cultured (37 C, 5% CO2) in sterile 25 cm
3 culture flasks 
in complete culture medium (CCM) comprising of Eagle's minimum essential 
media (10% foetal calf serum, 1% L-glutamine, 1% penicillin-streptomycin-
fungizone) until 90% con-fluency was reached (Wilson and Walker, 2010). 
Treatments were made from 1 mg/ml stocks of FA diluted in 0.1 M 
phosphate-buffered saline (PBS). 
 
 
2.3. Cell viability assay 
 
The cell viability and cytotoxicity of FA in SNO cells were 
 
determined via the MTT assay. SNO cells (15,000 cells) were seeded into a 
96-well microtitre plate in triplicate. Cells were incubated with FA 
concentrations (0e500 mg/mL) at 37 C for 24 h. Thereafter, the cells were 
incubated with MTT salt solution (5 mg/mL in 0.1 M PBS) and CCM (37 C, 4 
h). The supernatants were then aspirated and 100 mL dimethyl sulphoxide 
(DMSO) was added and incubated (37 C, 1 h). Optical density was measured 
using a microplate reader (Bio-Tek mQuant) at 570/690 nm. The 
concentration of FA that produced half the maximum inhibition (IC50) had 
been calculated via linear extrapolation. Two independent experiments were 
con-ducted to verify the IC50 which was used in all subsequent assays. All 
subsequent assays are representations of two experiments. 
 
 
2.4. ATP quantification assay 
 
Intracellular ATP levels were quantified using a CellTiter-Glo
®
 kit (Promega, 
Madison, USA). Briefly, 50 mL of cell suspension (20,000 cells/well in 0.1 M 
PBS) were seeded into a microtitre plate in triplicate. Thereafter, 20 mL of 
reagent was added followed by incubation (dark, 30min, room temperature 
(RT)). Luminescence, which was proportional to the level of intracellular 
ATP, was then detected using a Modulus™ microplate luminometer (Turner 
Bio-systems, Sunnyvale, USA) and expressed as relative light units (RLU). 
 
 
2.5. Glutathione assay 
 
Intracellular glutathione (GSH) levels were quantified using the GSH-Glo™ 
assay (Promega, Madison, USA). Briefly, 50 mL of cell suspension (20,000 
cells/well in 0.1 M PBS) were seeded into a microtitre plate in triplicate. A 5 
mM stock diluted in PBS was used to make GSH standards (0e50 mM). 
Subsequently, 50 mL per stan-dard and 50 mL of 2 GSH-Glo™ Reagent 
were added and incu-bated (30 min, dark, RT). Thereafter, 50 mL of 
Reconstituted Luciferin Detection Reagent was added and incubated (15 min, 
RT). Luminescence was measured using a Modulus™ microplate 
luminometer and expressed as relative fold change. 
 
 
2.6. TBARS assay 
 
The extent of lipid peroxidation was measured using the Thio-barbituric Acid 
Reactive Substance (TBARS) assay which measures the level of 
malondialdehyde (MDA), a by-product of lipid peroxi-dation and an indicator 
of oxidative stress (Fernandez et al., 1997). Supernatants per 
control/treatment were added into test tubes containing 2% H3PO4 (200 mL), 
7% H3PO4 (200 mL) and TBA/Butyl-ated hydroxytoluene solution (400 
mL) (Asakawa and Matsushita, 1979). Subsequently, MDA (1 mL) was 
added to the positive con-trol and hydrochloric acid (HCl) (400 mL) to the 
blank. Each was adjusted to pH 1.5. Samples were boiled (15 min) then 
allowed to cool to RT prior to the addition of butanol (1,500 mL). Each tube 
was vortexed and allowed to separate into two phases. The butanol phase was 
then transferred to sterile tubes and centrifuged (2,500g; 24 C; 6 min). 
Thereafter, each sample (100 mL) was transferred to a microtitre plate in 
triplicate. The absorbance was measured at 532/600 nm by means of a Bio-




2.7. LDH cytotoxicity detection assay 
 
Extracellular LDH levels were quantified using a Cytotoxicity Detection Kit 
(11644793001) (Roche, Mannheim, Germany). Briefly, supernatants (100 
mL) were added into a microtitre plate in tripli-cate. Thereafter, dye solution 
(INT/sodium lactate) (100 mL) and catalyst (diaphorase/NADþ) (100 mL) 
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incubation (dark, 25min, RT). Absorbance was measured at 500 nm using a 
spectrophotometer (Bio-Tek mQuant). 
 
2.8. Assessment of caspase activity 
 
The activities of caspase-3/7, -8 and -9 were detected with Caspase-Glo
®
 
assay (Promega, Madison, USA). Briefly, 50 mL of cell suspension (20,000 
cells/well in 0.1 M PBS) were seeded into a microtitre plate in triplicate. As 
per manufacturer's guidelines, Caspase-Glo
®
-3/-7, -8 and -9 reagents were 
reconstituted and added (20 mL). Thereafter, the plate was incubated (dark, 
30 min, RT). Luminescence was detected using a Modulus™ microplate 
luminometer and expressed as relative fold change. 
 
2.9. Western Blotting 
 
Western blotting was used to determine protein expression of Bax, Bcl-2, 
Smac/DIABLO and cleaved poly(ADP-ribose) polymer-ase-1 (PARP-1). 
Total protein was extracted using Cytobuster™ reagent (Novagen, San Diego, 
CA, USA), supplemented with prote-ase and phosphatase inhibitor (Roche, 
Germany, 05892791001 and 04906837001 respectively), as per 
manufacturer's instructions. Protein was quantified via the bicinchoninic acid 
assay (Sigma, Germany) (Bainor et al., 2011) and standardized to 1.5 mg/mL. 
Samples were boiled in Laemmli buffer [dH2O, 0.5 M Tris-HCl (pH 6.8), 3% 
glycerol, 10% SDS, 12% b-mercaptoethanol, 2% bromophenol blue] (1:4, 
20min) (Yang and Ma, 2009). Protein samples were separated using sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (4% stacking, 7% 
resolving) (1 h, 150 V) using a Bio-Rad compact power supply. Thereafter, 
the separated proteins were electro-transferred to a nitrocellulose membrane 
(400 mA; 1 h) and then blocked (1 h) in 5% bovine serum albumin in Tris-
buffered saline containing 0.5% Tween20 (TTBS). Membranes were subse-
quently immune-probed with primary antibody [Bax (610982), Bcl-2 (2827), 
Smac/DIABLO (110291), Cleaved PARP-1 (9541); 1:1000] (4 C, overnight). 
Membranes were then washed with TTBS and then exposed to secondary 
antibody [Bax, Bcl-2, Smac/DIABLO [rabbit (7076S), 1:5000]; Cleaved-
PARP-1 (1:10,000)] (1 h, RT). Membranes were washed again with TTBS 
and b-actin (A3854, 1:5000) was utilised to normalise protein expression. 
The Clarity Western ECL Substrate (Bio-Rad) detection reagents were used 
to detect chemiluminescent signal on the Alliance 2.7 image docu-mentation 
system (UViTech). Protein expression was analysed us-ing UviBand 
Advanced Image Analysis software v12.14 (UViTech). Data was expressed as 





2.10. SCGE (comet) assay 
 
The Comet assay was used to detect DNA damage (Singh et al., 1988). Three 
slides per treatment/control were prepared: the first layer contained 1% low 
melting point agarose (LMPA, 400 mL) (37 C); the second layer contained 
cell suspension (20,000 cells in 25 mL) in 0.5% LMPA (175 mL) and 
GelRed™ nucleic acid gel stain (1 mL) (Biotium, California, cat. no. 41003) 
(37 C); the third layer contained 0.5% LMPA (200 mL) (37 C). Solidified 
gels were sub-merged in cold cell lysis buffer (100 mM EDTA, 2.5 M NaCl, 
1% Triton X-100, 10% DMSO, and 10 mM Tris (pH 10)) and then incubated 
(1 h, 4 C). Thereafter, the slides were laid in electrophoresis buffer (1 mM 
Na2EDTA (pH 13) and 300 mM NaOH) (20min, RT) and then subjected to 
electrophoresis (25 V, 35 min, RT) using a Bio-Rad compact power supply. 
Using neutralisation buffer (0.4 M Tris (pH 7.4)), the slides were rinsed (three 
times, 5 min) and then viewed using a fluorescent microscope (Olympus IXSI 
inverted microscope, excitation: 510e560 nm; emission 590 nm). Images of 
50 cells and comets were captured in total from three slides per 
 
control/treatment. Lengths of cells and comet tails were measured using Soft 
imaging system (Life Science - 
©
Olympus Soft Imaging Solutions v5) and 
reported in mm. 
 
2.11. Hoechst staining assay 
 
To assess nuclear structure and cellular morphology, SNO cells were stained 
with Hoechst 33342 (H3570) (Invitrogen™, Eugene, Oregon, USA). Cells 
were seeded (500,000 cells) into a 6 well plate and treated in triplicate. Cells 
were thereafter washed (0.1 M PBS), fixed (10% paraformaldehyde, 5min) 
and washed again (0.1 M PBS). Hoechst working solution (10 mg/mL, 
Molecular Probes, Eugene, OR) was added and incubated (15 min, 37 C). 
Images were captured using a fluorescent microscope (350 nm excitation, 450 
nm emission). Ten images per treatment replicate were captured at 
magnifications 10 and 20 . 
 
 
2.12. Statistical analysis 
 
Statistical analyses were carried out using GraphPad Prism v5.0 software 
(GraphPad Software Inc., La Jolla, USA). The concentration-response-
inhibition equation produced an IC50 for MTT assay. The statistical 
significances were determined by unpaired t-test with Welch's correction 
(results reported as mean ± standard deviation (SD)) and a 95% confidence 




3.1. Cell viability 
 
The MTT assay was used to measure FA cytotoxicity in SNO cells and an 
IC50 of 78.81 mg/mL was calculated and used in all subse-quent assays (Fig. 
1). 
 
3.2. ATP quantification 
 
The concentration of ATP in SNO cells was assessed via lumin-ometry. The 
ATP levels were significantly reduced by FA with a 1.16-fold decrease 
(3,628,000 ± 79,920 RLU) compared to the control (4,212,000 ± 120,900 
RLU; p ¼ 0.006) (Fig. 2). 
 
3.3. Oxidative stress 
 
Lipid peroxidation by ROS was measured by quantifying the level of MDA, 
the end product of lipid peroxidation. Levels of extracellular MDA in FA 


















Fig. 1. FA induced a dose-dependent decrease in SNO cell viability (0e500 mg/mL) with 




















Fig. 2. Levels of ATP in control vs FA treated SNO cells. FA significantly decreased ATP 
levels (p ¼ 0.006). RLU: relative light units. *p < 0.05 relative to control. 
 
significantly increased by 1.23-fold compared to that of control cells (1.007 ± 
0.003 mM, p ¼ 0.0166) (Fig. 3a). There was a significant decrease in GSH 
levels (-1.62-fold) in FA treated SNO cells (0.6171 ± 0.006 mM) compared 
to that of the control (1.010 ± 0.006 mM, p < 0.0001) (Fig. 3b). 
 
 
3.4. Extracellular LDH levels 
 
FA induced significant SNO cell membrane damage when compared to 
control SNO cells as measured by increased extracel-lular LDH levels 
(control: 1.849 ± 0.018 Optical density (OD); FA: 2.122 ± 0.004 OD, p ¼ 
0.002) (Fig. 4). 
 
3.5. Caspase activation 
 
The activity of caspases-3/7, -8 and -9 were assessed via luminometry (Fig. 
5). FA significantly increased the activity of all caspases measured: caspase-
3/7 by 1.17-fold (p ¼ 0.0306); caspase-8 by 1.34-fold (p ¼ 0.013) and 
caspase-9 by 1.24-fold (p ¼ 0.0059) in SNO cells. 
 
 
3.6. Western blot analysis 
 
Western Blotting was used to determine the effect of FA on relative protein 
expression of pro-apoptotic proteins Bax, Smac/ DIABLO and anti-apoptotic 
protein Bcl-2 (Fig. 6). FA induced a significant 1.08-fold increase in Bax 
expression (0.0726 ± 0.0008 RBD vs. control: 0.0675 ± 0.0005 RBD, p ¼ 
0.0138); a 1.02-fold in-crease in Smac/DIABLO expression (1.026 ± 0.0287 
RBD vs. control: 1.003 ± 0.0033 RBD) and a significant -1.24-fold decrease 
in Bcl-2 expression (0.8131 ± 0.0176 RBD vs. control: 1.010 ± 0.0058 RBD, 
















Fig. 4. FA significantly increased LDH leakage in SNO cells indicative of membrane damage. 
LDH: lactate dehydrogenase, OD; optical density. **p < 0.005 relative to control. 
 
 
cleaved to produce a 24 kDa and 89 kDa fragment. FA significantly increased 
(1.53-fold) 24 kDa fragment of PARP-1 (2.021 ± 0.0771 RBD vs. control: 
1.325 ± 0.1117 RBD, p ¼ 0.0143) (Fig. 6). 
 
3.7. DNA damage 
 
The comet assay was used to assess DNA damage by FA in SNO cells. FA 
induced DNA damage in SNO cells with significantly increased comet tail 
lengths (Fig. 7a) as compared to control cells (5.926 ± 0.0795 mm vs. 
control: 3.092 ± 0.2102 mm, p < 0.0001) (Fig. 7b). 
 
 
3.8. Hoechst staining assay 
 
Late stages of apoptosis are characterized by nuclear conden-sation, apoptotic 
body formation and DNA fragmentation. Hoechst staining showed increased 
cell density and healthy cells undergo-ing various stages of mitosis in the 
untreated control (Fig. 8a), while FA induced nuclear condensation, apoptotic 





There is a high incidence of OC among black South African men and 
thousands of people worldwide (Siegel et al., 2016). FA is known to have low 
to moderate toxic effects in plants and has been suggested as a causative agent 
of OC (Nedelník, 2002), however the effects of FA in humans has not yet 
been conclusively explored. This study assessed the acute toxicity of FA on 
human oesophageal epithelial carcinoma (SNO) cells. 
 
















Fig. 3. Oxidative stress induced by FA in SNO cells. FA significantly increased levels of MDA (a by-product of lipid peroxidation) (p ¼ 0.0166) (a) with a corresponding decrease in levels of 































Fig. 5. Caspase activity was significantly influenced by FA. Activity of initiator caspase-8 (b) and -9 (c), as well as executioner caspase-3/7 (a) were significantly elevated in FA treated SNO cells. *p 











































































Fig. 8. (a). Uptake of Hoechst 33324 stain by untreated SNO cells (20 ). Diagram represents: 
(A-early prophase, B- metaphase, C- late anaphase, D-early telophase, E-late telophase 
(cytokinesis)); (b). Uptake of Hoechst 33324 stain by FA treated SNO cells (20 ). FA induced 
apoptosis (A-apoptotic body formation, B- chromatin condensation, C- DNA fragmentation and 
reduced SNO cell density as compared to control). 
 
 
antioxidant GSH lead to oxidative stress, accompanied by the oxidation of 
DNA and lipids (Circu and Aw, 2010). FA significantly increased the levels 
of ROS-induced lipid peroxidation (Fig. 3a) and simultaneously significantly 
decreased levels of GSH, compared to control cells (Fig. 3b) leading to 
oxidative stress.  
The lipophilic tail of FA causes damage to the lipid components of the cell 
membrane and compromises its integrity in the process (Dowhan, 1997; 
Fernandez-Pol, 1998). LDH is an enzyme found in the cytoplasm of healthy 
cells with intact cell membranes (Watanabe et al., 1995). An increase in 
extracellular LDH levels (Fig. 4) signifies cell membrane damage caused by 
lipid peroxida-tion and the FA lipophilic tail. 
 
Further, FA may disrupt membrane integrity by chelating diva-lent cations. 
FA sequesters divalent metal cations between the N atom of its pyridine ring 
and the carboxyl radical in its a-position, creating a five-membered direct link 
(G€aumann, 1958). Divalent metal cations contribute to membrane integrity 
by stabilising the ordered state of membranes. Divalent cations react with 
negatively charged phospholipids in membranes which are essential for nat-
ural processes such as signal transduction (Tr€auble and Eibl, 1974). Divalent 




 also inhibit permeability changes 
in membranes by blocking leakage at the site of lesion formation subsequent 
to binding of toxins to cells, and are known as membrane protective agents 
(Bashford et al., 1986). 
 
The mitochondrion is known as the cellular metabolic hub since one of its 
most important functions is aerobic respiration. The MTT assay measures 
metabolic activity of the mt respiratory chain by quantifying the ratio of 
reducing equivalents to oxidising equiva-lents in the cell (Mosmann, 1983). 
FA revealed a dose-dependent decrease in cellular metabolic activity and 
viability in SNO cells as 
 
observed by the MTT assay (Fig. 1). Reduced metabolic activity may be due 
to a decline in the rate of the Kreb's cycle which leads to a decreased output 
of reducing equivalents required for MTT salt reduction to generate a 
formazan product. On the other hand, as indicated by the TBARS assay, the 
level of lipid peroxidation was significantly increased (Fig. 3a). Hence, both 
the cell membrane of SNO cells and the mitochondria are also affected by 
FA.  
FA decreases the activity of succinate dehydrogenase and a-ketoglutarate 
dehydrogenase in the Kreb's cycle by influencing the mt proton gradient. This 
gradient is necessary for coupling of the ETC to oxidative phosphorylation in 
order to produce ATP (Telles-Pupulin et al., 1998). FA significantly decreased 
ATP levels in SNO cells (Fig. 2); also the lipophilic tail of FA may have 
impaired the activity of Cyt c oxidase resulting in uncoupling the ETC from 
ATP synthesis (Gaumann,€ 1958). Thus, the observed alterations in the 
cellular NADH/NADPH reductase system corresponds with the dose-
dependent decrease in ATP levels. FA disrupts the integrity of the mt 
membrane and processes that occur within mitochondria of SNO cells. Recent 
work by Sheik Abdul et al. proposed that FA induced oxidative and 
mitochondrial stress in the hepatocellular carcinoma HepG2 cell line (Sheik 
Abdul et al., 2016). 
 
Since mt disruption and ATP depletion are early events in apoptosis (Telles-
Pupulin et al., 1998), the expression and activities of apoptotic markers were 
analysed. The Bcl-2 family of proteins, particularly Bax and Bcl-2 are 
important in apoptosis. Mt perme-ability transition pores (MPTPs) in the mt 
membrane consist of and are regulated by Bax and Bcl-2. Bax, a pro-
apoptotic protein, in-duces the formation of MPTPs by interacting with lipids 
in the outer mt membrane (OMM). FA significantly increased Bax protein 
expression (Fig. 6). This suggests a role of FA in Zn2
þ
 chelation, since Zn2
þ
 
is an inhibitor of Bax and Zn2
þ
 chelation would allow for Bax activation 
(Ganju and Eastman, 2003). Bcl-2 is an anti-apoptotic protein and inhibitor of 
Bax (Hockenbery et al., 1990). FA caused a significant decrease in Bcl-2 
expression (Fig. 6), thus preventing its inhibitory effect on Bax activation. 
 
Upon formation of MPTPs, mt pro-apoptotic proteins such as Cyt c and 
Smac/DIABLO are released into the cytoplasm. Cyt c binds to Apaf-1, which 
recruits pro-caspase-9 to form an ATP-requiring apoptosome. This 
apoptosome cleaves pro-caspase-9 to form active caspase-9, which is the 
initiator caspase of the intrinsic pathway. Caspase-9 activates executioner 
caspase-3/7, which me-diates proteolysis of apoptotic cells. Caspase-8, the 
initiator caspase of the extrinsic pathway, activates Bid which activates Bax. 
The pro-apoptotic protein, Smac/DIABLO, functions to inhibit the activity of 
inhibitor of apoptosis proteins (IAPs), which inhibit caspase-3/7 and -9 
(Ashkenazi and Dixit, 1998; Green and Reed, 1998; Guicciardi and Gores, 
2005). FA increased Smac/DIABLO levels (Fig. 6) and significantly increased 
the activation of caspases -3/7, -8 and -9 (Fig. 5) in SNO cells, compared to 
control cells. 
 
Active caspase-3/7 cleaves the 75 kDa subunit of complex I of the ETC 
disrupting electron transport and mt membrane perme-ability (Ricci et al., 
2004) and further increasing ROS production, ATP depletion and mt damage. 
 
PARP-1, ATP-dependent Zn-finger endonuclease, is activated by caspase-3/7 
and binds to breaks of internucleosomal DNA. PARP-1 is a 113 kDa protein, 
which when cleaved, forms an 89 kDa (carboxyl-terminus catalytic fragment) 
and a 24 kDa fragment (amino-terminus DNA-binding domain). PARP-1 also 
contains a Zn-finger domain which can be chelated by FA, which causes 
PARP-1 cleavage and renders PARP-1 ineffective in its DNA binding and 
repair activity (Kaufmann et al., 1993). Zn inhibits PARP-1 cleavage and is 
therefore essential to allow for the binding of PARP-1 to DNA strand breaks. 
This is achieved by Zn inhibition of the catalytic function of caspase-3/7 by 
interaction with either or both of the conserved sites, Cys-285 and His-237. 
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by which Zn chelation would allow for PARP-1 cleavage to occur (Perry et 
al., 1997). A significant increase in the expression of the 24 kDa fragment of 
PARP-1 indicates that PARP-1 is cleaved by FA and contributes to DNA 
damage (Fig. 7b). This result may be due to the chelating effect of FA on Zn 
and hence the significant increase in caspase-3/7 activity. 
 
Late stages of apoptosis include condensation and damage of nuclear 
components followed by the formation of apoptotic bodies. FA caused 
nuclear condensation (Fig. 8b), significant DNA damage (Figs. 6 and 7b) and 
resulted in the formation of a substantial amount of apoptotic bodies (Fig. 8b) 
in SNO cells. These results are consistent with caspase and PARP-1 
activation, and confirms that FA is a potent inducer of apoptosis in SNO cells. 
 
The results of this study are consistent with previous studies which showed 
that FA induced DNA damage and decreased the expression of Zn-finger 
proteins via chelation; significantly inhibited cellular proliferation; increased 
expression of caspases-3/ 7, -9, four anti-inflammatory cytokines and cleaved 
PARP-1; induced changes in the cell cycle and ultimately induced apoptosis. 
The data led to the conclusion that FA had tumouristatic and tumouricidal 
effects on HNSCC (Stack et al., 2004; Jaglowski and Stack Jr., 2006, Ruda et 






FA increased oxidative stress and induced apoptosis via both the intrinsic and 
extrinsic pathways in SNO cells. Taken together, FA is a cytotoxic agent to 
human oesophageal SNO cells. Understanding the mechanism of toxicity of 
FA in humans may aid in preventing and treating the outcomes of consuming 
FA-contaminated agri-cultural produce. Additional studies need to determine 
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